STUDYID|DOMAIN|USUBJID|DSSEQ|DSGRPID|DSREFID|DSSPID|DSTERM|DSDECOD|DSCAT|DSSCAT|EPOCH|DSDTC|DSSTDTC|DSDY|DSSTDY
TRIAL STUDY 134XCP|DS|28FBEC95-59B8-4821-BD7A-125E2C87D71C|1||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1970-03-14|1960-01-02||
TRIAL STUDY 134XCP|DS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1|2||||||OTHER EVENT||OPEN LABEL TREATMENT|1967-03-13|1962-04-17||
TRIAL STUDY 134XCP|DS|1117C221-3530-45CB-82B2-B831C4DAD86B|3||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1963-02-03|1969-01-27||
TRIAL STUDY 134XCP|DS|3ACFF838-5B16-4898-9640-A60C85096F64|4||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1960-10-05|1969-09-12||
TRIAL STUDY 134XCP|DS|308F422A-B02B-4C76-86E7-834AAC127FE3|5||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1967-02-27|1961-09-28||
TRIAL STUDY 134XCP|DS|34A3AA01-3595-42C2-95C3-44E3AF77B28D|6||||||OTHER EVENT||WASHOUT|1972-07-08|1965-12-17||
TRIAL STUDY 134XCP|DS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70|7||||||OTHER EVENT||RUN-IN|1970-10-26|1968-06-19||
TRIAL STUDY 134XCP|DS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30|8||||||OTHER EVENT||OBSERVATION|1968-03-28|1970-07-12||
TRIAL STUDY 134XCP|DS|ECA054C6-EA0F-4D7B-905C-849EA4592624|9||||||PROTOCOL MILESTONE||TREATMENT|1965-03-30|1963-04-23||
TRIAL STUDY 134XCP|DS|83823CA3-1C1D-455E-BE49-DC5E3651A939|10||||||DISPOSITION EVENT||INDUCTION TREATMENT|1966-08-07|1968-02-10||
TRIAL STUDY 134XCP|DS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB|11||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1964-10-28|1970-06-23||
TRIAL STUDY 134XCP|DS|9C24F018-315A-4B9C-B89B-F54CA26452E7|12||||||DISPOSITION EVENT||TREATMENT|1968-07-27|1972-05-10||
TRIAL STUDY 134XCP|DS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A|13||||||OTHER EVENT||OBSERVATION|1960-07-05|1972-11-01||
TRIAL STUDY 134XCP|DS|8D48F229-F38B-4335-B8A7-0AA24C928707|14||||||OTHER EVENT||SCREENING|1960-11-18|1964-09-22||
TRIAL STUDY 134XCP|DS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6|15||||||DISPOSITION EVENT||BLINDED TREATMENT|1972-06-23|1965-06-10||
TRIAL STUDY 134XCP|DS|C882CB1F-C0DE-4BE5-B762-611333949C74|16||||||PROTOCOL MILESTONE||SCREENING|1969-02-13|1961-04-02||
TRIAL STUDY 134XCP|DS|7F3C3801-607B-4141-AA83-383FDFFD7152|17||||||OTHER EVENT||CONTINUATION TREATMENT|1971-05-25|1969-05-16||
TRIAL STUDY 134XCP|DS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB|18||||||PROTOCOL MILESTONE||TREATMENT|1970-05-20|1970-01-10||
TRIAL STUDY 134XCP|DS|67025219-DBC0-4222-9D04-7F23EE3D5806|19||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1971-08-09|1961-02-10||
TRIAL STUDY 134XCP|DS|A865B860-E5F2-423D-8110-58EBF7E470F3|20||||||PROTOCOL MILESTONE||WASHOUT|1964-08-19|1973-03-29||
TRIAL STUDY 134XCP|DS|E78B2C0E-81D6-4898-B78A-FE136029AEA4|21||||||OTHER EVENT||BASELINE|1965-07-29|1960-01-17||
TRIAL STUDY 134XCP|DS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53|22||||||PROTOCOL MILESTONE||RUN-IN|1963-10-29|1966-08-28||
TRIAL STUDY 134XCP|DS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF|23||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1962-02-28|1960-01-13||
TRIAL STUDY 134XCP|DS|55210E20-F6B9-446F-994D-2D9149E33BAF|24||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1971-03-04|1973-04-11||
TRIAL STUDY 134XCP|DS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450|25||||||DISPOSITION EVENT||TREATMENT|1970-02-10|1962-03-29||
TRIAL STUDY 134XCP|DS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A|26||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1970-03-21|1969-01-01||
TRIAL STUDY 134XCP|DS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7|27||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1965-09-16|1968-12-10||
TRIAL STUDY 134XCP|DS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D|28||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1966-09-20|1963-04-05||
TRIAL STUDY 134XCP|DS|CAD0ED37-954A-4935-8A7E-589EC108E141|29||||||PROTOCOL MILESTONE||SCREENING|1963-09-22|1969-04-23||
TRIAL STUDY 134XCP|DS|BC9A31E2-100C-4AC3-8910-A04309854590|30||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1970-08-14|1962-10-20||
TRIAL STUDY 134XCP|DS|13A424BB-CC85-41EC-BDED-165A29532DFF|31||||||OTHER EVENT||SCREENING|1963-12-24|1964-07-17||
TRIAL STUDY 134XCP|DS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3|32||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1966-07-01|1969-07-16||
TRIAL STUDY 134XCP|DS|059FE504-DEE4-4E24-AA80-3C64264636BF|33||||||OTHER EVENT||FOLLOW-UP|1964-07-21|1961-01-12||
TRIAL STUDY 134XCP|DS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236|34||||||OTHER EVENT||RUN-IN|1973-04-10|1968-08-15||
TRIAL STUDY 134XCP|DS|69BCF810-6748-43AA-BDFC-64EE1536CB47|35||||||PROTOCOL MILESTONE||FOLLOW-UP|1961-06-09|1962-07-19||
TRIAL STUDY 134XCP|DS|DCE71DE9-8DFB-4796-BC41-21930EC21925|36||||||OTHER EVENT||OBSERVATION|1968-05-17|1971-05-11||
TRIAL STUDY 134XCP|DS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19|37||||||PROTOCOL MILESTONE||RUN-IN|1963-03-04|1973-04-15||
TRIAL STUDY 134XCP|DS|97D06076-FE6B-4C77-BD5C-2E665F707C7A|38||||||PROTOCOL MILESTONE||FOLLOW-UP|1972-07-18|1972-01-11||
TRIAL STUDY 134XCP|DS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F|39||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-04-28|1966-04-06||
TRIAL STUDY 134XCP|DS|D5A1EB38-77EA-49A5-84CA-740A83D258AF|40||||||PROTOCOL MILESTONE||OBSERVATION|1967-09-07|1968-09-18||
TRIAL STUDY 134XCP|DS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5|41||||||OTHER EVENT||WASHOUT|1963-08-02|1965-06-16||
TRIAL STUDY 134XCP|DS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6|42||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1962-12-23|1965-10-10||
TRIAL STUDY 134XCP|DS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE|43||||||PROTOCOL MILESTONE||TREATMENT|1972-07-21|1960-10-25||
TRIAL STUDY 134XCP|DS|640DDEF5-748A-4F92-A13D-15D1C7CE0800|44||||||OTHER EVENT||CONTINUATION TREATMENT|1968-08-12|1967-07-28||
TRIAL STUDY 134XCP|DS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED|45||||||DISPOSITION EVENT||BLINDED TREATMENT|1968-12-18|1970-11-24||
TRIAL STUDY 134XCP|DS|EBC7BF7B-18C6-463C-8500-027B2A6966DB|46||||||OTHER EVENT||FOLLOW-UP|1961-08-09|1970-02-18||
TRIAL STUDY 134XCP|DS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C|47||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1970-05-08|1966-09-15||
TRIAL STUDY 134XCP|DS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD|48||||||OTHER EVENT||BLINDED TREATMENT|1960-03-08|1968-09-30||
TRIAL STUDY 134XCP|DS|74741526-F925-4AA5-9BE3-F3B3884BEE68|49||||||OTHER EVENT||BLINDED TREATMENT|1968-04-13|1973-02-04||
TRIAL STUDY 134XCP|DS|25088C28-0FA3-4005-90C3-CCF9C6FF5851|50||||||OTHER EVENT||OBSERVATION|1963-08-04|1963-02-14||
TRIAL STUDY 134XCP|DS|9BF13738-0A50-46E6-A3DA-AC956A361B97|51||||||PROTOCOL MILESTONE||RUN-IN|1965-03-26|1970-04-09||
TRIAL STUDY 134XCP|DS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0|52||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1961-06-14|1972-09-11||
TRIAL STUDY 134XCP|DS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF|53||||||OTHER EVENT||INDUCTION TREATMENT|1968-01-30|1972-01-20||
TRIAL STUDY 134XCP|DS|5AEA7EE9-1095-4967-B833-7665B6A71B31|54||||||OTHER EVENT||SCREENING|1960-01-12|1971-05-10||
TRIAL STUDY 134XCP|DS|241CD521-D0BD-40BB-ABA2-B8C8E500B491|55||||||PROTOCOL MILESTONE||OBSERVATION|1963-10-03|1971-10-22||
TRIAL STUDY 134XCP|DS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F|56||||||DISPOSITION EVENT||OBSERVATION|1970-09-16|1967-08-15||
TRIAL STUDY 134XCP|DS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8|57||||||DISPOSITION EVENT||WASHOUT|1971-05-22|1961-11-27||
TRIAL STUDY 134XCP|DS|FD609B1C-D1E7-4349-B036-DF0126D96A52|58||||||OTHER EVENT||OPEN LABEL TREATMENT|1969-03-18|1970-07-02||
TRIAL STUDY 134XCP|DS|DEB0593B-E3FD-471C-A800-43058AC5FD86|59||||||PROTOCOL MILESTONE||BASELINE|1966-08-01|1963-07-26||
TRIAL STUDY 134XCP|DS|596BD728-2487-44E4-AFB1-8A4331EEDDF6|60||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1962-12-07|1968-12-28||
TRIAL STUDY 134XCP|DS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF|61||||||DISPOSITION EVENT||FOLLOW-UP|1970-03-03|1971-05-16||
TRIAL STUDY 134XCP|DS|0365EB5F-7364-4B1F-8919-543D8D21B045|62||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1972-09-01|1966-10-08||
TRIAL STUDY 134XCP|DS|364277A8-875C-4A6F-93C3-C913BB3C97CA|63||||||DISPOSITION EVENT||OBSERVATION|1965-12-17|1964-10-26||
TRIAL STUDY 134XCP|DS|B824951F-58EE-4003-A2AD-A91AADBBAC0D|64||||||PROTOCOL MILESTONE||RUN-IN|1970-09-20|1961-11-29||
TRIAL STUDY 134XCP|DS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0|65||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1973-04-13|1967-12-02||
TRIAL STUDY 134XCP|DS|A108F408-906C-4320-965A-D5D295BC5C31|66||||||DISPOSITION EVENT||TREATMENT|1973-05-18|1971-12-16||
TRIAL STUDY 134XCP|DS|8E627D27-4855-4E1B-B823-1E14368973AF|67||||||DISPOSITION EVENT||WASHOUT|1961-11-08|1965-12-18||
TRIAL STUDY 134XCP|DS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2|68||||||OTHER EVENT||RUN-IN|1971-12-02|1964-04-09||
TRIAL STUDY 134XCP|DS|483D89E1-45FD-41D4-B9E0-22FFB41D323A|69||||||DISPOSITION EVENT||BLINDED TREATMENT|1960-01-21|1962-09-30||
TRIAL STUDY 134XCP|DS|2CCBED9D-5F24-4ED8-B575-8523C820A227|70||||||OTHER EVENT||OBSERVATION|1969-04-15|1972-07-02||
TRIAL STUDY 134XCP|DS|F4D6A28D-569F-4639-ACE2-10EB517128B2|71||||||PROTOCOL MILESTONE||TREATMENT|1961-12-06|1962-01-01||
TRIAL STUDY 134XCP|DS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA|72||||||DISPOSITION EVENT||INDUCTION TREATMENT|1961-02-23|1969-10-02||
TRIAL STUDY 134XCP|DS|415EF35E-6D99-48F8-80A1-89A4CDC621B8|73||||||PROTOCOL MILESTONE||SCREENING|1962-10-03|1961-06-14||
TRIAL STUDY 134XCP|DS|AA0F6192-A377-43C6-8203-BDF7553AEA88|74||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1965-11-04|1966-07-23||
TRIAL STUDY 134XCP|DS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162|75||||||DISPOSITION EVENT||BLINDED TREATMENT|1965-04-04|1969-06-09||
TRIAL STUDY 134XCP|DS|A848B1B5-679F-4C45-AD73-6506604C835E|76||||||PROTOCOL MILESTONE||TREATMENT|1962-08-28|1962-07-14||
TRIAL STUDY 134XCP|DS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47|77||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1960-10-14|1970-12-29||
TRIAL STUDY 134XCP|DS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6|78||||||PROTOCOL MILESTONE||WASHOUT|1973-06-23|1969-12-13||
TRIAL STUDY 134XCP|DS|FC155F37-522F-4620-BBFF-4999D37C1379|79||||||PROTOCOL MILESTONE||TREATMENT|1969-07-09|1963-02-23||
TRIAL STUDY 134XCP|DS|20F817BC-4C89-4F6C-AA45-36CE786A73A8|80||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1962-04-27|1971-12-04||
TRIAL STUDY 134XCP|DS|99058E64-9873-4CD5-BB31-28C08758A1B5|81||||||OTHER EVENT||OBSERVATION|1964-07-13|1961-02-19||
TRIAL STUDY 134XCP|DS|656B6693-1C1C-433B-84E3-77E89F0B543E|82||||||OTHER EVENT||RUN-IN|1966-07-15|1967-05-17||
TRIAL STUDY 134XCP|DS|43C443F9-AB0F-44BE-B28B-63A60EE09205|83||||||DISPOSITION EVENT||RUN-IN|1964-04-15|1968-04-12||
TRIAL STUDY 134XCP|DS|37FF91B1-CE3C-4587-85CE-F76B880D40E7|84||||||OTHER EVENT||BLINDED TREATMENT|1960-02-19|1970-12-01||
TRIAL STUDY 134XCP|DS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03|85||||||OTHER EVENT||TREATMENT|1967-02-18|1971-12-16||
TRIAL STUDY 134XCP|DS|49017491-2C28-4F86-BF72-CF83651052F6|86||||||OTHER EVENT||BLINDED TREATMENT|1968-12-02|1962-12-27||
TRIAL STUDY 134XCP|DS|DAA65EE6-66ED-4354-935B-1347E1B572A5|87||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1963-12-13|1962-02-24||
TRIAL STUDY 134XCP|DS|A440A3E5-F87D-4306-9195-3A842F0DDE33|88||||||DISPOSITION EVENT||OBSERVATION|1971-01-24|1963-08-24||
TRIAL STUDY 134XCP|DS|48BBE085-BD68-451A-9700-6A1AB18D84EE|89||||||PROTOCOL MILESTONE||RUN-IN|1971-06-03|1973-06-01||
TRIAL STUDY 134XCP|DS|F38055A2-11E2-437B-BD6A-662D81521F1D|90||||||PROTOCOL MILESTONE||SCREENING|1969-04-04|1971-10-13||
TRIAL STUDY 134XCP|DS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC|91||||||OTHER EVENT||RUN-IN|1964-03-07|1960-12-27||
TRIAL STUDY 134XCP|DS|22B0F097-D571-4E65-9B58-BEF2C3482F05|92||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1963-01-22|1968-07-05||
TRIAL STUDY 134XCP|DS|F56B6C70-0513-4032-A0BE-B961F6F2EF30|93||||||OTHER EVENT||RUN-IN|1973-02-20|1972-11-01||
TRIAL STUDY 134XCP|DS|8E385A66-25C9-417E-9298-FB87A73B661F|94||||||DISPOSITION EVENT||WASHOUT|1960-09-10|1971-07-23||
TRIAL STUDY 134XCP|DS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3|95||||||DISPOSITION EVENT||INDUCTION TREATMENT|1968-05-16|1961-06-15||
TRIAL STUDY 134XCP|DS|D0AE2069-B430-4771-9A8C-0F5442DFCECE|96||||||OTHER EVENT||BLINDED TREATMENT|1963-07-22|1967-08-21||
TRIAL STUDY 134XCP|DS|CF214007-AC24-4760-AEDE-F78CDE3D9351|97||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1970-10-14|1963-06-18||
TRIAL STUDY 134XCP|DS|E996BE19-2824-49D3-944F-B777F3D8E746|98||||||DISPOSITION EVENT||RUN-IN|1968-02-09|1972-03-25||
TRIAL STUDY 134XCP|DS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC|99||||||OTHER EVENT||SCREENING|1964-11-23|1967-09-12||
TRIAL STUDY 134XCP|DS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE|100||||||DISPOSITION EVENT||OBSERVATION|1968-10-19|1965-06-20||
TRIAL STUDY 134XCP|DS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5|101||||||PROTOCOL MILESTONE||BASELINE|1962-04-20|1960-07-29||
TRIAL STUDY 134XCP|DS|1F75D53C-E8AA-45DA-8410-F00266080E80|102||||||PROTOCOL MILESTONE||WASHOUT|1960-02-21|1962-06-28||
TRIAL STUDY 134XCP|DS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666|103||||||PROTOCOL MILESTONE||RUN-IN|1962-04-03|1972-06-16||
TRIAL STUDY 134XCP|DS|EE14E53E-19A8-4441-BF82-31444CBC8B49|104||||||OTHER EVENT||WASHOUT|1968-04-11|1960-08-16||
TRIAL STUDY 134XCP|DS|DAF741EF-DCCF-4E18-844B-05640A94C181|105||||||DISPOSITION EVENT||BASELINE|1962-01-24|1972-09-20||
TRIAL STUDY 134XCP|DS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54|106||||||PROTOCOL MILESTONE||OBSERVATION|1963-11-13|1963-05-13||
TRIAL STUDY 134XCP|DS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D|107||||||OTHER EVENT||TREATMENT|1963-08-14|1970-12-08||
TRIAL STUDY 134XCP|DS|CF3E1636-762F-4821-A44E-455F33F5E4CC|108||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1973-03-24|1966-11-03||
TRIAL STUDY 134XCP|DS|3846A0A8-2D38-44C9-A579-84C66315C436|109||||||DISPOSITION EVENT||INDUCTION TREATMENT|1962-02-20|1970-10-21||
TRIAL STUDY 134XCP|DS|75B429C2-E173-4F72-8D4A-76F62C97F006|110||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1967-12-31|1969-11-10||
TRIAL STUDY 134XCP|DS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381|111||||||OTHER EVENT||RUN-IN|1966-01-09|1961-01-14||
TRIAL STUDY 134XCP|DS|8065F0B9-9183-43E4-998A-D2F096D87998|112||||||PROTOCOL MILESTONE||FOLLOW-UP|1967-01-15|1973-03-18||
TRIAL STUDY 134XCP|DS|697EB3B7-5AD1-4D1D-BB53-BB0556915957|113||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1962-06-21|1964-11-06||
TRIAL STUDY 134XCP|DS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91|114||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1962-08-04|1960-05-28||
TRIAL STUDY 134XCP|DS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94|115||||||OTHER EVENT||BASELINE|1966-03-23|1972-05-26||
TRIAL STUDY 134XCP|DS|52EC57AA-56E4-47A8-AADA-36F62653B423|116||||||PROTOCOL MILESTONE||SCREENING|1968-01-12|1969-11-26||
TRIAL STUDY 134XCP|DS|F09C04A4-4F9E-4033-9115-81C6007DE8B4|117||||||DISPOSITION EVENT||BASELINE|1969-02-12|1962-10-09||
TRIAL STUDY 134XCP|DS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3|118||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-01-16|1971-12-31||
TRIAL STUDY 134XCP|DS|4779A01C-1219-46AC-B0F7-71C9717A2B45|119||||||OTHER EVENT||INDUCTION TREATMENT|1960-03-05|1968-04-23||
TRIAL STUDY 134XCP|DS|5F5C5DED-7547-40D2-9B34-77B37CCD7732|120||||||OTHER EVENT||OBSERVATION|1963-06-20|1963-02-16||
TRIAL STUDY 134XCP|DS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857|121||||||OTHER EVENT||INDUCTION TREATMENT|1960-11-22|1971-09-09||
TRIAL STUDY 134XCP|DS|48348DF0-33DA-457F-86C6-797FF7B32857|122||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1966-03-02|1964-09-08||
TRIAL STUDY 134XCP|DS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4|123||||||OTHER EVENT||OBSERVATION|1967-11-20|1963-02-18||
TRIAL STUDY 134XCP|DS|396CC122-5F23-418D-A75E-572ADF4FD6C1|124||||||OTHER EVENT||OBSERVATION|1968-12-29|1968-11-27||
TRIAL STUDY 134XCP|DS|9CF3CD51-5D5B-40E6-8F13-B314911BE461|125||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1967-01-11|1972-09-20||
TRIAL STUDY 134XCP|DS|CB3B9054-5CDC-418D-8071-7429B1702587|126||||||PROTOCOL MILESTONE||FOLLOW-UP|1973-06-28|1964-04-27||
TRIAL STUDY 134XCP|DS|1AC4DE34-3486-41FB-A979-8B368912F75A|127||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1964-12-27|1969-09-27||
TRIAL STUDY 134XCP|DS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E|128||||||OTHER EVENT||RUN-IN|1960-10-15|1963-05-21||
TRIAL STUDY 134XCP|DS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585|129||||||OTHER EVENT||OBSERVATION|1966-04-06|1961-11-23||
TRIAL STUDY 134XCP|DS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF|130||||||OTHER EVENT||INDUCTION TREATMENT|1968-09-19|1967-05-10||
TRIAL STUDY 134XCP|DS|0194CD2F-7ABE-4BEE-A6FC-61298880173D|131||||||PROTOCOL MILESTONE||FOLLOW-UP|1965-10-13|1960-09-20||
TRIAL STUDY 134XCP|DS|A6E531C7-1BC1-402E-9B2E-03B44313487B|132||||||PROTOCOL MILESTONE||SCREENING|1960-11-24|1962-08-05||
TRIAL STUDY 134XCP|DS|47C0D833-BEAB-4BF2-B028-891808E729F1|133||||||OTHER EVENT||SCREENING|1964-11-20|1965-01-10||
TRIAL STUDY 134XCP|DS|BA1773BD-AA89-45FC-B7C6-C5267770B197|134||||||OTHER EVENT||TREATMENT|1970-02-07|1966-02-04||
TRIAL STUDY 134XCP|DS|03D3DDC6-03FA-469A-B8A4-D504919B68F1|135||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1972-02-10|1971-08-01||
TRIAL STUDY 134XCP|DS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8|136||||||DISPOSITION EVENT||BASELINE|1962-04-05|1961-01-20||
TRIAL STUDY 134XCP|DS|1873D4CC-40B7-4303-9F07-8FE0E4595361|137||||||DISPOSITION EVENT||WASHOUT|1961-04-27|1960-11-18||
TRIAL STUDY 134XCP|DS|23E5569E-B324-4399-AC8A-5EC7C343C1D3|138||||||DISPOSITION EVENT||TREATMENT|1964-10-01|1972-05-27||
TRIAL STUDY 134XCP|DS|B349DD89-C41F-470E-8B54-B3589F0982FE|139||||||OTHER EVENT||OPEN LABEL TREATMENT|1969-08-24|1963-04-22||
TRIAL STUDY 134XCP|DS|415D178A-275A-440C-8617-154441A48F8D|140||||||PROTOCOL MILESTONE||WASHOUT|1972-10-13|1968-05-26||
TRIAL STUDY 134XCP|DS|C23917E6-6CA5-4314-A59D-A0298483BF53|141||||||OTHER EVENT||WASHOUT|1971-01-16|1960-07-29||
TRIAL STUDY 134XCP|DS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E|142||||||PROTOCOL MILESTONE||WASHOUT|1964-12-18|1964-03-30||
TRIAL STUDY 134XCP|DS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2|143||||||PROTOCOL MILESTONE||TREATMENT|1961-09-19|1973-07-09||
TRIAL STUDY 134XCP|DS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820|144||||||OTHER EVENT||BLINDED TREATMENT|1964-11-24|1964-06-22||
TRIAL STUDY 134XCP|DS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF|145||||||PROTOCOL MILESTONE||OBSERVATION|1963-09-23|1967-01-27||
TRIAL STUDY 134XCP|DS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6|146||||||DISPOSITION EVENT||TREATMENT|1968-05-21|1962-12-01||
TRIAL STUDY 134XCP|DS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115|147||||||PROTOCOL MILESTONE||SCREENING|1962-11-01|1971-05-23||
TRIAL STUDY 134XCP|DS|EDB6B55B-7903-4F89-805C-32F067C2A230|148||||||OTHER EVENT||OPEN LABEL TREATMENT|1966-04-11|1962-01-09||
TRIAL STUDY 134XCP|DS|8F6772DE-E4CA-4706-8754-740D3859ABDF|149||||||OTHER EVENT||OBSERVATION|1973-06-12|1968-12-31||
TRIAL STUDY 134XCP|DS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD|150||||||PROTOCOL MILESTONE||TREATMENT|1963-09-05|1964-05-20||
TRIAL STUDY 134XCP|DS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB|151||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1972-08-11|1966-01-27||
TRIAL STUDY 134XCP|DS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7|152||||||OTHER EVENT||FOLLOW-UP|1972-05-06|1967-10-05||
TRIAL STUDY 134XCP|DS|B3987A78-0D92-419D-A289-039C87C6C202|153||||||PROTOCOL MILESTONE||TREATMENT|1960-02-22|1970-05-04||
TRIAL STUDY 134XCP|DS|2A0D27D8-EC46-4B40-B1BB-078268E03355|154||||||OTHER EVENT||BASELINE|1960-11-22|1962-05-14||
TRIAL STUDY 134XCP|DS|65EBB2AF-B97A-403A-9FB5-31C1559074C4|155||||||PROTOCOL MILESTONE||FOLLOW-UP|1971-01-24|1970-12-07||
TRIAL STUDY 134XCP|DS|90892428-99C3-4E7D-B3A8-3C526812EDD2|156||||||OTHER EVENT||BLINDED TREATMENT|1967-10-14|1973-01-05||
TRIAL STUDY 134XCP|DS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF|157||||||OTHER EVENT||WASHOUT|1961-08-06|1966-12-17||
TRIAL STUDY 134XCP|DS|2B443EEA-B98B-47D9-8D27-801582804AB5|158||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1972-08-06|1961-12-02||
TRIAL STUDY 134XCP|DS|0278D57A-30D6-4B7A-A45C-EB973F6686C6|159||||||DISPOSITION EVENT||BASELINE|1972-04-02|1961-03-03||
TRIAL STUDY 134XCP|DS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6|160||||||PROTOCOL MILESTONE||OBSERVATION|1972-12-03|1962-08-16||
TRIAL STUDY 134XCP|DS|67D6A191-10C7-4414-BA63-DB7701998DF0|161||||||PROTOCOL MILESTONE||OBSERVATION|1967-12-21|1968-02-19||
TRIAL STUDY 134XCP|DS|499B5A47-893A-40DE-9B64-60967378C81A|162||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1969-01-30|1962-03-28||
TRIAL STUDY 134XCP|DS|984103CA-F301-4510-A9DD-4916FA858EA2|163||||||OTHER EVENT||SCREENING|1963-10-19|1971-05-18||
TRIAL STUDY 134XCP|DS|50E626B3-9133-4A50-8907-2388DAC22AD1|164||||||PROTOCOL MILESTONE||TREATMENT|1960-08-14|1961-02-28||
TRIAL STUDY 134XCP|DS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21|165||||||OTHER EVENT||OPEN LABEL TREATMENT|1967-12-23|1965-05-06||
TRIAL STUDY 134XCP|DS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0|166||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1961-04-22|1963-01-05||
TRIAL STUDY 134XCP|DS|F8F17A43-A74B-4570-8A06-D7657A4636B4|167||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1963-03-14|1968-11-29||
TRIAL STUDY 134XCP|DS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74|168||||||OTHER EVENT||WASHOUT|1963-08-23|1960-02-14||
TRIAL STUDY 134XCP|DS|1177FD36-AAE8-4139-991A-A8C98B607565|169||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1962-01-05|1964-12-27||
TRIAL STUDY 134XCP|DS|8C57F469-7CDF-493A-9839-C179D912A8A5|170||||||PROTOCOL MILESTONE||OBSERVATION|1964-04-28|1964-03-25||
TRIAL STUDY 134XCP|DS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0|171||||||OTHER EVENT||OBSERVATION|1965-04-16|1965-07-27||
TRIAL STUDY 134XCP|DS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A|172||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1967-06-27|1970-06-17||
TRIAL STUDY 134XCP|DS|0AE36450-F37E-4F97-A250-79166011FCD7|173||||||OTHER EVENT||SCREENING|1965-10-02|1969-07-21||
TRIAL STUDY 134XCP|DS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098|174||||||PROTOCOL MILESTONE||FOLLOW-UP|1971-10-23|1967-02-01||
TRIAL STUDY 134XCP|DS|707FC46F-B8B1-456B-9E09-CABC86EA61D5|175||||||OTHER EVENT||WASHOUT|1968-04-14|1973-05-09||
TRIAL STUDY 134XCP|DS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F|176||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1973-05-06|1960-12-23||
TRIAL STUDY 134XCP|DS|70196099-5D40-4048-AABF-EB40CE345328|177||||||DISPOSITION EVENT||BASELINE|1970-02-28|1967-10-01||
TRIAL STUDY 134XCP|DS|F9D4C544-F217-4676-AC40-F71CC48045AF|178||||||DISPOSITION EVENT||SCREENING|1971-08-04|1967-06-18||
TRIAL STUDY 134XCP|DS|E6A42133-B082-4BD7-B840-A60E49E0562B|179||||||OTHER EVENT||OPEN LABEL TREATMENT|1962-06-28|1968-09-09||
TRIAL STUDY 134XCP|DS|72C9FDBC-AA86-4001-9820-90AAF5422074|180||||||OTHER EVENT||INDUCTION TREATMENT|1970-10-01|1964-12-07||
TRIAL STUDY 134XCP|DS|186520B9-8AAD-4063-B48F-16040EF49944|181||||||PROTOCOL MILESTONE||FOLLOW-UP|1968-03-12|1963-07-20||
TRIAL STUDY 134XCP|DS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF|182||||||DISPOSITION EVENT||BASELINE|1967-08-12|1969-06-28||
TRIAL STUDY 134XCP|DS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1|183||||||PROTOCOL MILESTONE||TREATMENT|1960-07-21|1962-07-22||
TRIAL STUDY 134XCP|DS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB|184||||||OTHER EVENT||OPEN LABEL TREATMENT|1964-12-07|1963-02-08||
TRIAL STUDY 134XCP|DS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE|185||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1972-06-09|1962-12-19||
TRIAL STUDY 134XCP|DS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA|186||||||PROTOCOL MILESTONE||RUN-IN|1970-12-30|1961-07-12||
TRIAL STUDY 134XCP|DS|460486B3-B7C8-4B54-848B-21BA899EAAD6|187||||||OTHER EVENT||RUN-IN|1965-07-20|1968-06-14||
TRIAL STUDY 134XCP|DS|A068436F-E26E-44C5-8959-0BCBA28832D1|188||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-07-21|1971-04-17||
TRIAL STUDY 134XCP|DS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5|189||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1971-12-18|1970-09-18||
TRIAL STUDY 134XCP|DS|E065D436-92D2-453F-86A7-27F70FE1FD03|190||||||DISPOSITION EVENT||OBSERVATION|1967-11-24|1970-06-20||
TRIAL STUDY 134XCP|DS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7|191||||||PROTOCOL MILESTONE||BASELINE|1962-01-04|1968-12-31||
TRIAL STUDY 134XCP|DS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D|192||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1963-11-26|1970-06-24||
TRIAL STUDY 134XCP|DS|D108D040-7177-4A14-8CA7-748D59DC5F8B|193||||||DISPOSITION EVENT||BLINDED TREATMENT|1964-03-04|1965-04-15||
TRIAL STUDY 134XCP|DS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8|194||||||OTHER EVENT||OPEN LABEL TREATMENT|1973-01-27|1967-08-22||
TRIAL STUDY 134XCP|DS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1|195||||||OTHER EVENT||RUN-IN|1972-09-17|1960-06-14||
TRIAL STUDY 134XCP|DS|580CCA66-3D51-4A5C-80E1-361A90369055|196||||||DISPOSITION EVENT||BASELINE|1966-01-25|1960-12-22||
TRIAL STUDY 134XCP|DS|DAB276EB-3581-4C20-88AC-5A3D267E54D8|197||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1962-10-04|1961-08-14||
TRIAL STUDY 134XCP|DS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02|198||||||OTHER EVENT||TREATMENT|1961-08-07|1971-05-24||
TRIAL STUDY 134XCP|DS|5B703A43-A280-4D6A-AC40-FF5187521DB2|199||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1965-08-20|1961-06-24||
TRIAL STUDY 134XCP|DS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4|200||||||DISPOSITION EVENT||TREATMENT|1971-02-16|1968-02-06||
TRIAL STUDY 134XCP|DS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6|201||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1964-12-02|1971-03-10||
TRIAL STUDY 134XCP|DS|51F3D3C1-3361-499F-B037-CCE8AB989989|202||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1962-11-06|1962-11-01||
TRIAL STUDY 134XCP|DS|231D401F-CA93-49E0-AC5C-C7F636343D2F|203||||||OTHER EVENT||WASHOUT|1972-10-06|1970-12-14||
TRIAL STUDY 134XCP|DS|2704A3C0-3345-48E5-AC9B-C00EA51AB085|204||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1970-05-03|1970-09-20||
TRIAL STUDY 134XCP|DS|2F636370-94FE-4BC0-9E16-DDD42D19A985|205||||||OTHER EVENT||BASELINE|1969-11-16|1969-09-21||
TRIAL STUDY 134XCP|DS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735|206||||||OTHER EVENT||CONTINUATION TREATMENT|1972-04-21|1969-01-04||
TRIAL STUDY 134XCP|DS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966|207||||||PROTOCOL MILESTONE||RUN-IN|1963-07-21|1961-04-10||
TRIAL STUDY 134XCP|DS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50|208||||||OTHER EVENT||OPEN LABEL TREATMENT|1965-10-22|1970-07-23||
TRIAL STUDY 134XCP|DS|A1FAB383-1757-4832-B888-90C133842EF8|209||||||PROTOCOL MILESTONE||FOLLOW-UP|1969-07-25|1962-05-09||
TRIAL STUDY 134XCP|DS|72AA1945-E676-4485-BD7F-6B969E314D83|210||||||PROTOCOL MILESTONE||SCREENING|1972-02-07|1969-04-23||
TRIAL STUDY 134XCP|DS|B297C689-0D99-4E36-9F27-F93D4F43E2DD|211||||||DISPOSITION EVENT||BLINDED TREATMENT|1964-05-09|1973-06-29||
TRIAL STUDY 134XCP|DS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E|212||||||OTHER EVENT||CONTINUATION TREATMENT|1973-07-15|1966-01-30||
TRIAL STUDY 134XCP|DS|3F18534E-367D-45C8-BB08-C82151A0CF00|213||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1968-09-12|1960-12-19||
TRIAL STUDY 134XCP|DS|81C10FB0-3B47-46D8-B8B7-9C772246CA55|214||||||OTHER EVENT||INDUCTION TREATMENT|1973-04-10|1969-09-02||
TRIAL STUDY 134XCP|DS|67C99F41-D839-4B8E-9220-6EC161FCD457|215||||||OTHER EVENT||WASHOUT|1960-07-01|1964-08-21||
TRIAL STUDY 134XCP|DS|76B9C25F-B418-4979-9E18-4372C8AA700C|216||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1970-05-11|1971-08-17||
TRIAL STUDY 134XCP|DS|9F622B53-71F8-4362-99A5-251993E3A946|217||||||OTHER EVENT||RUN-IN|1966-12-18|1962-05-31||
TRIAL STUDY 134XCP|DS|8F2DC6EB-0264-4112-B379-17896F4266E4|218||||||PROTOCOL MILESTONE||FOLLOW-UP|1971-01-19|1961-06-02||
TRIAL STUDY 134XCP|DS|448246D1-5625-4F69-B214-3A8848E86C28|219||||||PROTOCOL MILESTONE||WASHOUT|1960-09-03|1963-03-11||
TRIAL STUDY 134XCP|DS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6|220||||||DISPOSITION EVENT||RUN-IN|1966-08-10|1965-06-07||
TRIAL STUDY 134XCP|DS|27DDBB16-ED11-45B6-987D-FB0D8223B993|221||||||OTHER EVENT||WASHOUT|1973-04-18|1973-08-03||
TRIAL STUDY 134XCP|DS|5545846C-F90F-4346-A075-05999641B872|222||||||DISPOSITION EVENT||BLINDED TREATMENT|1968-05-25|1965-10-09||
TRIAL STUDY 134XCP|DS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1|223||||||PROTOCOL MILESTONE||FOLLOW-UP|1966-02-18|1963-03-19||
TRIAL STUDY 134XCP|DS|111541DB-D863-4C68-9E62-B8741A62401C|224||||||PROTOCOL MILESTONE||OBSERVATION|1965-09-03|1960-02-28||
TRIAL STUDY 134XCP|DS|5095C113-7278-4D41-B860-0DF6B9B98738|225||||||DISPOSITION EVENT||SCREENING|1961-05-14|1967-07-19||
TRIAL STUDY 134XCP|DS|61319D2E-A512-425F-9301-BAD27B5F5C9B|226||||||OTHER EVENT||OPEN LABEL TREATMENT|1960-09-04|1963-11-13||
TRIAL STUDY 134XCP|DS|3B865A8F-949B-4B64-A818-85472EABB8FB|227||||||PROTOCOL MILESTONE||FOLLOW-UP|1963-09-26|1968-11-19||
TRIAL STUDY 134XCP|DS|A6909912-22B9-4EE7-AEDF-F791F243A6B7|228||||||OTHER EVENT||SCREENING|1960-01-15|1962-04-07||
TRIAL STUDY 134XCP|DS|83C8AAD3-B22D-42C6-870A-D069FAC601F3|229||||||OTHER EVENT||TREATMENT|1961-10-06|1967-08-23||
TRIAL STUDY 134XCP|DS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5|230||||||PROTOCOL MILESTONE||FOLLOW-UP|1973-09-02|1960-05-19||
TRIAL STUDY 134XCP|DS|937BF41A-157D-45F6-9797-2C5D19D100E6|231||||||DISPOSITION EVENT||TREATMENT|1967-02-07|1967-06-28||
TRIAL STUDY 134XCP|DS|1BA56D89-E536-491E-AD6A-190A07331BEA|232||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1969-07-02|1972-01-16||
TRIAL STUDY 134XCP|DS|BE208D93-7322-427F-A8E5-1DBE5040BE8F|233||||||DISPOSITION EVENT||WASHOUT|1967-07-06|1960-10-14||
TRIAL STUDY 134XCP|DS|A58C5E7B-21EC-4F59-BB74-3264AC945F61|234||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1969-11-06|1964-12-02||
TRIAL STUDY 134XCP|DS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2|235||||||OTHER EVENT||OPEN LABEL TREATMENT|1965-10-02|1965-03-10||
TRIAL STUDY 134XCP|DS|434B4F6A-C436-4F92-8FA5-9C2F1964098A|236||||||PROTOCOL MILESTONE||RUN-IN|1968-01-16|1963-03-06||
TRIAL STUDY 134XCP|DS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7|237||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1966-08-27|1968-09-13||
TRIAL STUDY 134XCP|DS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB|238||||||OTHER EVENT||RUN-IN|1969-03-31|1964-02-26||
TRIAL STUDY 134XCP|DS|73C4A4D7-2177-47F3-818A-C0774F5E4A08|239||||||DISPOSITION EVENT||OBSERVATION|1969-10-23|1966-09-17||
TRIAL STUDY 134XCP|DS|4E3929B3-63F2-4E89-8EB4-60991E7284E1|240||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1962-12-26|1971-05-10||
TRIAL STUDY 134XCP|DS|F26E2F67-3F90-448C-92BB-AD60E71D5664|241||||||PROTOCOL MILESTONE||TREATMENT|1973-04-11|1966-03-31||
TRIAL STUDY 134XCP|DS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980|242||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1968-11-24|1973-03-20||
TRIAL STUDY 134XCP|DS|F2F1151C-F987-49CE-BC16-719DD339DBE7|243||||||DISPOSITION EVENT||RUN-IN|1962-11-24|1970-12-07||
TRIAL STUDY 134XCP|DS|F88FCFA6-90D7-4033-86DF-223A63A6152D|244||||||PROTOCOL MILESTONE||WASHOUT|1965-12-08|1967-11-07||
TRIAL STUDY 134XCP|DS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E|245||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1963-02-08|1963-11-08||
TRIAL STUDY 134XCP|DS|7D35B2F5-7334-448B-B4E1-14671B850B6A|246||||||OTHER EVENT||BLINDED TREATMENT|1971-04-10|1960-03-18||
TRIAL STUDY 134XCP|DS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9|247||||||DISPOSITION EVENT||WASHOUT|1965-11-05|1967-09-26||
TRIAL STUDY 134XCP|DS|B09D371C-2E5C-4F84-986E-5A603C0C4A28|248||||||DISPOSITION EVENT||FOLLOW-UP|1963-08-30|1961-06-20||
TRIAL STUDY 134XCP|DS|11CB653E-F113-4639-B15C-B236A2F65F47|249||||||PROTOCOL MILESTONE||BASELINE|1965-03-18|1963-02-09||
TRIAL STUDY 134XCP|DS|2AB992E7-55B7-4327-987C-47FD605B7D78|250||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1969-06-06|1963-11-06||
TRIAL STUDY 134XCP|DS|6AF1B0B0-9923-459A-8629-5E628400AD00|251||||||DISPOSITION EVENT||BLINDED TREATMENT|1969-08-25|1960-01-12||
TRIAL STUDY 134XCP|DS|E1305E4E-DF64-4FD1-B0B2-131459AB629D|252||||||DISPOSITION EVENT||BASELINE|1965-04-16|1960-01-04||
TRIAL STUDY 134XCP|DS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066|253||||||PROTOCOL MILESTONE||WASHOUT|1973-03-10|1972-03-18||
TRIAL STUDY 134XCP|DS|0FD7F837-3D76-4A1C-B414-373B55A39506|254||||||OTHER EVENT||RUN-IN|1962-02-02|1964-08-27||
TRIAL STUDY 134XCP|DS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA|255||||||PROTOCOL MILESTONE||WASHOUT|1972-06-21|1970-08-19||
TRIAL STUDY 134XCP|DS|92FB0125-67D2-41CC-9116-8C949F15614A|256||||||DISPOSITION EVENT||FOLLOW-UP|1960-04-20|1970-12-31||
TRIAL STUDY 134XCP|DS|7042617F-0C29-4928-B3ED-9549A53BC195|257||||||OTHER EVENT||TREATMENT|1972-12-24|1967-03-24||
TRIAL STUDY 134XCP|DS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD|258||||||OTHER EVENT||CONTINUATION TREATMENT|1967-12-23|1966-07-17||
TRIAL STUDY 134XCP|DS|6633CC54-D711-4780-A833-A71756D8B234|259||||||PROTOCOL MILESTONE||OBSERVATION|1970-09-11|1969-01-22||
TRIAL STUDY 134XCP|DS|84C642FE-6D84-4525-AB1C-15FAF740D63B|260||||||DISPOSITION EVENT||WASHOUT|1972-05-25|1962-07-20||
TRIAL STUDY 134XCP|DS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7|261||||||OTHER EVENT||FOLLOW-UP|1969-10-20|1969-09-16||
TRIAL STUDY 134XCP|DS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62|262||||||DISPOSITION EVENT||TREATMENT|1964-01-23|1969-08-20||
TRIAL STUDY 134XCP|DS|A0757669-2DF6-4E78-A021-9C777BEF5697|263||||||DISPOSITION EVENT||WASHOUT|1961-03-28|1971-08-29||
TRIAL STUDY 134XCP|DS|DAF7255A-888D-43D3-97B8-5E432938747F|264||||||DISPOSITION EVENT||TREATMENT|1971-12-13|1962-07-12||
TRIAL STUDY 134XCP|DS|51989FEC-B63E-4F58-B748-2FF5E73E5D14|265||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1961-07-23|1967-04-29||
TRIAL STUDY 134XCP|DS|776299DC-1CD5-448F-82C2-C1659CEE689D|266||||||OTHER EVENT||BASELINE|1968-09-22|1968-04-15||
TRIAL STUDY 134XCP|DS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7|267||||||PROTOCOL MILESTONE||BASELINE|1960-09-12|1971-07-25||
TRIAL STUDY 134XCP|DS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1|268||||||OTHER EVENT||SCREENING|1972-10-17|1964-03-09||
TRIAL STUDY 134XCP|DS|054D4740-C675-4904-B912-B00A0B089F12|269||||||PROTOCOL MILESTONE||BASELINE|1967-04-03|1969-08-09||
TRIAL STUDY 134XCP|DS|9548556E-EECF-4460-A7DD-D93F853E9EA8|270||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1970-02-11|1967-03-12||
TRIAL STUDY 134XCP|DS|0BCF6152-3718-402C-9333-A3EFBB3086FF|271||||||OTHER EVENT||OPEN LABEL TREATMENT|1968-12-23|1961-05-06||
TRIAL STUDY 134XCP|DS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7|272||||||DISPOSITION EVENT||RUN-IN|1963-03-11|1972-05-01||
TRIAL STUDY 134XCP|DS|EED12AC0-1CBD-4D42-8786-91834AB33A46|273||||||PROTOCOL MILESTONE||RUN-IN|1961-07-20|1972-01-10||
TRIAL STUDY 134XCP|DS|F30DC3E9-E919-4920-87FE-103CD85D89FA|274||||||OTHER EVENT||SCREENING|1967-01-06|1962-10-06||
TRIAL STUDY 134XCP|DS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B|275||||||OTHER EVENT||BLINDED TREATMENT|1968-12-01|1969-08-12||
TRIAL STUDY 134XCP|DS|729D254F-628C-4D35-8906-A1344833A610|276||||||OTHER EVENT||INDUCTION TREATMENT|1968-12-22|1970-12-05||
TRIAL STUDY 134XCP|DS|A78936A2-B8B1-4D07-8679-E324F6447EFF|277||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1963-03-10|1965-08-21||
TRIAL STUDY 134XCP|DS|239B331A-08CD-41D9-BBB8-CE229480FC12|278||||||OTHER EVENT||TREATMENT|1972-12-09|1962-12-06||
TRIAL STUDY 134XCP|DS|958D39CD-D511-40C8-A0A6-8A138225470B|279||||||DISPOSITION EVENT||FOLLOW-UP|1969-12-24|1962-10-19||
TRIAL STUDY 134XCP|DS|5DA21FE5-E5B9-4461-9509-94AA264B59A8|280||||||DISPOSITION EVENT||BASELINE|1970-09-22|1966-02-21||
TRIAL STUDY 134XCP|DS|B125DCB9-1705-430B-9982-A20E7C4CA6A8|281||||||PROTOCOL MILESTONE||WASHOUT|1969-08-11|1961-11-10||
TRIAL STUDY 134XCP|DS|95C72325-301E-40D4-AA2D-49B80067FE23|282||||||DISPOSITION EVENT||BLINDED TREATMENT|1972-01-02|1973-05-26||
TRIAL STUDY 134XCP|DS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5|283||||||OTHER EVENT||SCREENING|1964-08-13|1966-11-01||
TRIAL STUDY 134XCP|DS|7DF25CA4-0846-4180-9356-F53C704F0233|284||||||OTHER EVENT||RUN-IN|1972-01-29|1968-11-10||
TRIAL STUDY 134XCP|DS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5|285||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1970-05-28|1965-06-19||
TRIAL STUDY 134XCP|DS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6|286||||||OTHER EVENT||OBSERVATION|1964-06-06|1970-01-14||
TRIAL STUDY 134XCP|DS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6|287||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1967-01-26|1960-01-12||
TRIAL STUDY 134XCP|DS|2C15756E-1096-403B-989D-D2C3D31396A9|288||||||DISPOSITION EVENT||OBSERVATION|1965-05-20|1973-04-16||
TRIAL STUDY 134XCP|DS|CD103276-37FC-4E40-A0C8-8D1300D21AE1|289||||||OTHER EVENT||BLINDED TREATMENT|1969-08-23|1968-08-15||
TRIAL STUDY 134XCP|DS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9|290||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1972-10-28|1968-06-23||
TRIAL STUDY 134XCP|DS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A|291||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1968-01-10|1971-01-17||
TRIAL STUDY 134XCP|DS|7B583F10-E460-4B25-8A6B-530A154442CD|292||||||DISPOSITION EVENT||TREATMENT|1970-09-14|1963-03-26||
TRIAL STUDY 134XCP|DS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6|293||||||OTHER EVENT||RUN-IN|1961-01-06|1961-04-24||
TRIAL STUDY 134XCP|DS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA|294||||||PROTOCOL MILESTONE||SCREENING|1970-02-17|1970-07-05||
TRIAL STUDY 134XCP|DS|51FE575E-2161-414B-B772-9F1888E7C5CC|295||||||DISPOSITION EVENT||OBSERVATION|1966-10-17|1964-09-04||
TRIAL STUDY 134XCP|DS|991C72FC-777F-4CED-824B-A4DECA57BE99|296||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1968-02-25|1968-07-22||
TRIAL STUDY 134XCP|DS|FFECA538-8D16-421C-ACA2-4A769BC15D7D|297||||||OTHER EVENT||SCREENING|1968-02-02|1969-09-02||
TRIAL STUDY 134XCP|DS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E|298||||||OTHER EVENT||SCREENING|1968-06-06|1964-08-06||
TRIAL STUDY 134XCP|DS|54507F00-0C16-4F35-A762-104B47390283|299||||||OTHER EVENT||RUN-IN|1960-04-22|1964-06-28||
TRIAL STUDY 134XCP|DS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566|300||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1973-08-04|1962-02-07||
TRIAL STUDY 134XCP|DS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1|301||||||DISPOSITION EVENT||TREATMENT|1971-08-10|1964-10-02||
TRIAL STUDY 134XCP|DS|CF8F9036-3380-4A0B-B17A-7EF814B02700|302||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1972-04-22|1971-02-13||
TRIAL STUDY 134XCP|DS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D|303||||||OTHER EVENT||TREATMENT|1963-11-25|1971-04-18||
TRIAL STUDY 134XCP|DS|58360390-F6AB-41D7-9A0D-1039E795403E|304||||||OTHER EVENT||OPEN LABEL TREATMENT|1964-04-08|1973-04-02||
TRIAL STUDY 134XCP|DS|61B02780-0C99-47F8-93B2-CA839876604E|305||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1965-04-03|1962-07-25||
TRIAL STUDY 134XCP|DS|1381458A-D702-467D-ADCA-984EE7BD894D|306||||||PROTOCOL MILESTONE||OBSERVATION|1965-12-14|1970-12-03||
TRIAL STUDY 134XCP|DS|04211DA3-CFD5-4750-9D61-C91FF7BC338A|307||||||OTHER EVENT||CONTINUATION TREATMENT|1963-07-07|1964-04-05||
TRIAL STUDY 134XCP|DS|EF707A48-6FAD-47C0-913A-5CBCACA539E0|308||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1966-02-07|1964-07-16||
TRIAL STUDY 134XCP|DS|C896767E-2418-4226-A8AE-D875DA40F9FB|309||||||OTHER EVENT||BLINDED TREATMENT|1969-11-06|1968-09-06||
TRIAL STUDY 134XCP|DS|666BC019-B828-4DB4-BD2F-973BA689C9E7|310||||||PROTOCOL MILESTONE||FOLLOW-UP|1962-08-05|1971-10-18||
TRIAL STUDY 134XCP|DS|91282D87-4943-4527-8F33-27A5C153951C|311||||||PROTOCOL MILESTONE||OBSERVATION|1965-07-05|1972-10-02||
TRIAL STUDY 134XCP|DS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A|312||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1971-12-15|1971-02-22||
TRIAL STUDY 134XCP|DS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2|313||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1965-03-03|1968-08-05||
TRIAL STUDY 134XCP|DS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1|314||||||OTHER EVENT||BLINDED TREATMENT|1969-03-23|1963-03-08||
TRIAL STUDY 134XCP|DS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6|315||||||OTHER EVENT||FOLLOW-UP|1964-09-27|1960-10-13||
TRIAL STUDY 134XCP|DS|0320460C-3770-486A-85EB-ECD133AE6EFA|316||||||PROTOCOL MILESTONE||WASHOUT|1962-11-26|1971-05-24||
TRIAL STUDY 134XCP|DS|810B0B08-9236-41EC-8879-924661FA224E|317||||||PROTOCOL MILESTONE||SCREENING|1970-09-23|1963-02-09||
TRIAL STUDY 134XCP|DS|BA3B0D91-DC95-4916-8ACA-71451447BE81|318||||||DISPOSITION EVENT||BASELINE|1968-03-07|1971-04-11||
TRIAL STUDY 134XCP|DS|DE385129-5FB9-43C3-9FB1-005886674C9B|319||||||PROTOCOL MILESTONE||TREATMENT|1972-05-03|1969-07-04||
TRIAL STUDY 134XCP|DS|8AE8077F-A13C-4593-B012-213A5EBE0A1D|320||||||OTHER EVENT||SCREENING|1967-12-18|1962-01-28||
TRIAL STUDY 134XCP|DS|72FCE18B-B3D6-45AC-993F-9883E4D11313|321||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1973-06-17|1967-10-19||
TRIAL STUDY 134XCP|DS|1123F894-0821-41DF-9C28-ED6BC4A7098C|322||||||DISPOSITION EVENT||BLINDED TREATMENT|1968-04-25|1962-05-26||
TRIAL STUDY 134XCP|DS|42DD827A-E788-4E61-8E9F-421136A16166|323||||||OTHER EVENT||BASELINE|1963-12-11|1961-08-25||
TRIAL STUDY 134XCP|DS|CC1E2338-4454-4CBA-8848-0B994C459F05|324||||||PROTOCOL MILESTONE||BASELINE|1969-09-22|1971-05-31||
TRIAL STUDY 134XCP|DS|ED04E60D-256A-4DB9-9290-4EFD0602A130|325||||||DISPOSITION EVENT||RUN-IN|1965-02-15|1968-07-28||
TRIAL STUDY 134XCP|DS|C70F82F6-3280-429D-9657-CDFBA6B7F626|326||||||DISPOSITION EVENT||WASHOUT|1970-11-09|1965-04-16||
TRIAL STUDY 134XCP|DS|D735D137-2C27-4F27-BA18-9A0F7FF0B145|327||||||DISPOSITION EVENT||FOLLOW-UP|1971-09-24|1967-01-04||
TRIAL STUDY 134XCP|DS|B00194E0-0E85-46DD-86C3-CD9048535986|328||||||PROTOCOL MILESTONE||BASELINE|1966-09-12|1970-09-26||
TRIAL STUDY 134XCP|DS|B4F372E9-C461-414A-95B4-93CA0221D396|329||||||OTHER EVENT||FOLLOW-UP|1960-01-14|1964-01-31||
TRIAL STUDY 134XCP|DS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7|330||||||DISPOSITION EVENT||RUN-IN|1961-09-27|1966-07-26||
TRIAL STUDY 134XCP|DS|E43169E4-8B57-47D7-9C91-D42E40DD579B|331||||||OTHER EVENT||CONTINUATION TREATMENT|1963-06-23|1973-07-04||
TRIAL STUDY 134XCP|DS|066393EE-D112-41DD-AF8F-65EF57A4415B|332||||||DISPOSITION EVENT||BASELINE|1960-03-10|1960-07-10||
TRIAL STUDY 134XCP|DS|573C9228-D341-491C-9D66-0D0435E2C631|333||||||DISPOSITION EVENT||INDUCTION TREATMENT|1972-11-29|1964-07-24||
TRIAL STUDY 134XCP|DS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36|334||||||DISPOSITION EVENT||SCREENING|1970-10-12|1965-12-21||
TRIAL STUDY 134XCP|DS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF|335||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1966-05-11|1970-06-26||
TRIAL STUDY 134XCP|DS|61C75130-5C1A-4B8D-804C-92D3288B55D2|336||||||PROTOCOL MILESTONE||TREATMENT|1971-05-01|1972-12-15||
TRIAL STUDY 134XCP|DS|90AFB57A-125C-4C08-AE92-061F66FC2DAC|337||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1972-06-02|1968-10-29||
TRIAL STUDY 134XCP|DS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4|338||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1966-11-29|1964-12-19||
TRIAL STUDY 134XCP|DS|01A42FAE-1EE2-4203-A62E-E368F31434F7|339||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1968-05-03|1961-03-12||
TRIAL STUDY 134XCP|DS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74|340||||||DISPOSITION EVENT||INDUCTION TREATMENT|1963-02-01|1966-01-03||
TRIAL STUDY 134XCP|DS|92232C8B-0D28-4E2A-AA56-BA938429CCBF|341||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1969-04-04|1961-05-04||
TRIAL STUDY 134XCP|DS|F4F12AAA-E825-45D7-B414-A06F2D20381A|342||||||OTHER EVENT||INDUCTION TREATMENT|1968-06-27|1970-08-17||
TRIAL STUDY 134XCP|DS|6CF611F2-686E-4AE9-B491-32157710F46D|343||||||OTHER EVENT||WASHOUT|1968-03-06|1966-02-09||
TRIAL STUDY 134XCP|DS|417DBC64-7BF9-4EB8-A14B-C5F63541F826|344||||||OTHER EVENT||CONTINUATION TREATMENT|1968-11-18|1968-05-12||
TRIAL STUDY 134XCP|DS|C3EF644E-25DC-4E0D-9073-735AED77EFAF|345||||||DISPOSITION EVENT||RUN-IN|1965-07-23|1961-05-22||
TRIAL STUDY 134XCP|DS|CAE5F41C-0560-4782-BA27-E314BF7E66B6|346||||||DISPOSITION EVENT||WASHOUT|1967-01-24|1962-01-06||
TRIAL STUDY 134XCP|DS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05|347||||||PROTOCOL MILESTONE||WASHOUT|1969-09-27|1968-06-09||
TRIAL STUDY 134XCP|DS|F34E7DCC-8637-463D-88E6-28AEBF495E9B|348||||||OTHER EVENT||OBSERVATION|1965-11-22|1972-12-20||
TRIAL STUDY 134XCP|DS|69530FE0-6896-4585-8B20-29AE90DB91F5|349||||||OTHER EVENT||INDUCTION TREATMENT|1964-01-16|1962-05-28||
TRIAL STUDY 134XCP|DS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6|350||||||PROTOCOL MILESTONE||TREATMENT|1969-10-20|1965-07-31||
TRIAL STUDY 134XCP|DS|F1EF928C-B819-4620-8991-ABDC4E182217|351||||||OTHER EVENT||BASELINE|1967-06-14|1966-01-07||
TRIAL STUDY 134XCP|DS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC|352||||||PROTOCOL MILESTONE||WASHOUT|1971-11-02|1962-07-16||
TRIAL STUDY 134XCP|DS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1|353||||||PROTOCOL MILESTONE||TREATMENT|1972-10-30|1966-02-16||
TRIAL STUDY 134XCP|DS|27D5690D-BCB3-4FEC-988C-666C29D5239A|354||||||DISPOSITION EVENT||OBSERVATION|1964-04-13|1967-03-04||
TRIAL STUDY 134XCP|DS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69|355||||||OTHER EVENT||OBSERVATION|1961-04-10|1971-02-25||
TRIAL STUDY 134XCP|DS|8E25F21F-A565-40CB-B0D7-6CC496171293|356||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1966-01-12|1969-07-30||
TRIAL STUDY 134XCP|DS|8CDD2247-485D-495C-9186-FF4CA3FFC32E|357||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1967-01-07|1963-11-04||
TRIAL STUDY 134XCP|DS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13|358||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1963-06-07|1967-10-20||
TRIAL STUDY 134XCP|DS|C004A8EB-220F-4FC5-A150-B5159DCA84D9|359||||||PROTOCOL MILESTONE||SCREENING|1963-08-21|1962-10-18||
TRIAL STUDY 134XCP|DS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E|360||||||OTHER EVENT||CONTINUATION TREATMENT|1967-12-27|1972-06-05||
TRIAL STUDY 134XCP|DS|AE127EDD-D708-4B1A-95F7-176A541A9584|361||||||OTHER EVENT||OPEN LABEL TREATMENT|1961-05-24|1965-10-29||
TRIAL STUDY 134XCP|DS|F642D4A0-A67F-4A10-BB21-E4644E963D45|362||||||PROTOCOL MILESTONE||WASHOUT|1965-07-20|1968-05-05||
TRIAL STUDY 134XCP|DS|933A6DFF-D519-46F4-AB52-78E6A898E4A1|363||||||DISPOSITION EVENT||WASHOUT|1966-11-22|1969-04-25||
TRIAL STUDY 134XCP|DS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD|364||||||OTHER EVENT||SCREENING|1961-09-21|1966-09-19||
TRIAL STUDY 134XCP|DS|38E177D4-1A58-4E78-90B7-85F76BF66826|365||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1970-04-07|1970-11-23||
TRIAL STUDY 134XCP|DS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9|366||||||DISPOSITION EVENT||TREATMENT|1962-11-03|1969-11-19||
TRIAL STUDY 134XCP|DS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B|367||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1972-10-20|1968-04-17||
TRIAL STUDY 134XCP|DS|50CFC814-7135-4356-BAC2-3F975B9F6AE3|368||||||DISPOSITION EVENT||BLINDED TREATMENT|1970-08-04|1962-09-27||
TRIAL STUDY 134XCP|DS|8A639816-D878-4FD7-AF28-CF9EA2236462|369||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1969-06-23|1964-09-15||
TRIAL STUDY 134XCP|DS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19|370||||||DISPOSITION EVENT||RUN-IN|1969-04-24|1967-09-10||
TRIAL STUDY 134XCP|DS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3|371||||||DISPOSITION EVENT||TREATMENT|1963-09-25|1960-04-04||
TRIAL STUDY 134XCP|DS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790|372||||||OTHER EVENT||OPEN LABEL TREATMENT|1962-03-22|1969-08-28||
TRIAL STUDY 134XCP|DS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43|373||||||OTHER EVENT||TREATMENT|1963-01-08|1969-07-26||
TRIAL STUDY 134XCP|DS|30419F44-B519-488C-A505-F23D88A46024|374||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1967-06-27|1961-05-09||
TRIAL STUDY 134XCP|DS|2AF06F66-5E51-4AC9-AF62-A34329724F7D|375||||||PROTOCOL MILESTONE||BASELINE|1962-12-12|1969-12-31||
TRIAL STUDY 134XCP|DS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829|376||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1967-04-26|1969-03-15||
TRIAL STUDY 134XCP|DS|94F4C997-3114-4444-BF89-E762226AAC89|377||||||OTHER EVENT||BLINDED TREATMENT|1965-03-31|1965-08-14||
TRIAL STUDY 134XCP|DS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7|378||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1966-07-24|1972-02-11||
TRIAL STUDY 134XCP|DS|D20DE6F0-DA30-4453-8F80-61093BF046A6|379||||||OTHER EVENT||OBSERVATION|1970-12-23|1963-05-12||
TRIAL STUDY 134XCP|DS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3|380||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1962-11-08|1965-10-26||
TRIAL STUDY 134XCP|DS|F20939CF-C668-4514-A2CF-63723560FA46|381||||||OTHER EVENT||INDUCTION TREATMENT|1973-02-24|1963-05-24||
TRIAL STUDY 134XCP|DS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791|382||||||OTHER EVENT||BASELINE|1961-01-30|1963-11-01||
TRIAL STUDY 134XCP|DS|9A60A414-54A0-4A7F-84EE-FCB8246D2477|383||||||OTHER EVENT||TREATMENT|1972-12-11|1965-05-17||
TRIAL STUDY 134XCP|DS|8D546F1C-E719-4C03-A66A-9916EFF2A144|384||||||DISPOSITION EVENT||SCREENING|1964-03-23|1962-02-26||
TRIAL STUDY 134XCP|DS|B998085D-F227-46C8-B2D8-37E97BA799D2|385||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1969-10-01|1960-09-15||
TRIAL STUDY 134XCP|DS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9|386||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1962-11-18|1960-08-20||
TRIAL STUDY 134XCP|DS|537CE647-EA58-430C-B37B-F56BF20B5AF0|387||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1962-08-27|1965-05-09||
TRIAL STUDY 134XCP|DS|3464201C-9704-40B6-B3B3-2BADE02BD58F|388||||||DISPOSITION EVENT||SCREENING|1971-10-28|1967-06-11||
TRIAL STUDY 134XCP|DS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7|389||||||PROTOCOL MILESTONE||FOLLOW-UP|1962-09-23|1969-08-19||
TRIAL STUDY 134XCP|DS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB|390||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1966-12-07|1968-07-06||
TRIAL STUDY 134XCP|DS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD|391||||||DISPOSITION EVENT||BLINDED TREATMENT|1968-09-15|1970-06-05||
TRIAL STUDY 134XCP|DS|11A6144A-895B-4143-85D2-69952C6D452C|392||||||DISPOSITION EVENT||WASHOUT|1964-08-06|1961-04-10||
TRIAL STUDY 134XCP|DS|8958D35E-F685-4542-AE01-625133F1EF7D|393||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1973-02-08|1971-02-17||
TRIAL STUDY 134XCP|DS|00982640-C826-4CD4-B927-A311227E63CC|394||||||OTHER EVENT||OBSERVATION|1972-07-08|1961-10-26||
TRIAL STUDY 134XCP|DS|C213CAA8-2FAC-402C-A19E-11A60708A71A|395||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1961-02-02|1961-11-10||
TRIAL STUDY 134XCP|DS|F0559682-CD36-4ED0-8082-A54D40305512|396||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1965-11-27|1972-04-18||
TRIAL STUDY 134XCP|DS|C004A4D5-DBD0-4967-9597-8C1653AB8298|397||||||OTHER EVENT||OPEN LABEL TREATMENT|1961-11-21|1970-01-29||
TRIAL STUDY 134XCP|DS|ABB838A1-2387-471E-8F50-1F48205BC8EE|398||||||DISPOSITION EVENT||OBSERVATION|1962-02-17|1969-05-09||
TRIAL STUDY 134XCP|DS|88126417-8564-4659-AA60-63642067113D|399||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1961-12-10|1961-05-02||
TRIAL STUDY 134XCP|DS|6ADA444E-F1B4-4E59-9F2D-26DC78845397|400||||||OTHER EVENT||BLINDED TREATMENT|1961-03-05|1962-08-03||
TRIAL STUDY 134XCP|DS|85060A90-92F7-4440-AD1C-62A70C2FD5CB|401||||||PROTOCOL MILESTONE||SCREENING|1973-01-19|1960-01-07||
TRIAL STUDY 134XCP|DS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0|402||||||PROTOCOL MILESTONE||BASELINE|1964-01-02|1961-12-18||
TRIAL STUDY 134XCP|DS|170052E6-031C-48EF-9CE4-CA84ED6B77FF|403||||||DISPOSITION EVENT||BASELINE|1963-04-04|1971-09-21||
TRIAL STUDY 134XCP|DS|D3F628DE-8358-4C2C-B474-763E48719E5E|404||||||DISPOSITION EVENT||BASELINE|1969-10-12|1960-11-22||
TRIAL STUDY 134XCP|DS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F|405||||||OTHER EVENT||SCREENING|1966-07-19|1972-09-11||
TRIAL STUDY 134XCP|DS|4395486D-C521-4478-9442-68CF0344C6FB|406||||||PROTOCOL MILESTONE||RUN-IN|1969-07-13|1970-08-13||
TRIAL STUDY 134XCP|DS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317|407||||||DISPOSITION EVENT||INDUCTION TREATMENT|1960-08-04|1968-03-05||
TRIAL STUDY 134XCP|DS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1|408||||||PROTOCOL MILESTONE||SCREENING|1964-07-15|1961-09-08||
TRIAL STUDY 134XCP|DS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9|409||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1973-08-26|1969-10-18||
TRIAL STUDY 134XCP|DS|19394300-46A6-484F-AE02-50BDD39096E3|410||||||DISPOSITION EVENT||OBSERVATION|1966-11-18|1961-02-19||
TRIAL STUDY 134XCP|DS|8C89BD60-3504-4F8B-8F33-7F0C949DB407|411||||||PROTOCOL MILESTONE||SCREENING|1971-12-22|1970-01-02||
TRIAL STUDY 134XCP|DS|4746A481-011E-4376-9D2F-5E57F560A6DE|412||||||DISPOSITION EVENT||RUN-IN|1964-10-06|1964-04-20||
TRIAL STUDY 134XCP|DS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0|413||||||PROTOCOL MILESTONE||RUN-IN|1963-05-11|1964-07-21||
TRIAL STUDY 134XCP|DS|04F5220E-7A8C-4982-9379-496306612E33|414||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1970-10-25|1963-07-06||
TRIAL STUDY 134XCP|DS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B|415||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1972-04-22|1970-11-25||
TRIAL STUDY 134XCP|DS|73BDFAA2-6260-4E1D-8039-7523F0C52873|416||||||OTHER EVENT||TREATMENT|1967-05-02|1962-10-08||
TRIAL STUDY 134XCP|DS|147C2E77-A2C5-4219-9BB5-D209813E563B|417||||||PROTOCOL MILESTONE||WASHOUT|1969-08-07|1960-12-05||
TRIAL STUDY 134XCP|DS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6|418||||||OTHER EVENT||WASHOUT|1967-07-25|1962-10-12||
TRIAL STUDY 134XCP|DS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E|419||||||DISPOSITION EVENT||OBSERVATION|1971-02-08|1964-12-20||
TRIAL STUDY 134XCP|DS|25E17A89-8A2F-4870-B076-1D32634F5620|420||||||OTHER EVENT||SCREENING|1961-02-16|1967-11-21||
TRIAL STUDY 134XCP|DS|B7B67C06-0802-4E69-A5A1-469213BE7E48|421||||||PROTOCOL MILESTONE||RUN-IN|1967-11-28|1968-06-24||
TRIAL STUDY 134XCP|DS|626E3EA7-423B-434F-89E4-CA076A39B8DB|422||||||PROTOCOL MILESTONE||RUN-IN|1969-10-01|1970-07-31||
TRIAL STUDY 134XCP|DS|98ED3A38-1E74-470E-BF45-0D1E905BEF36|423||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1962-02-09|1965-03-21||
TRIAL STUDY 134XCP|DS|99DF7819-987E-4E55-89FD-FF49E7C02A5A|424||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1963-01-25|1964-09-17||
TRIAL STUDY 134XCP|DS|05481BE7-9309-4356-B46E-9C2525D2C54E|425||||||DISPOSITION EVENT||FOLLOW-UP|1965-10-11|1972-12-13||
TRIAL STUDY 134XCP|DS|2F49D512-0A23-4D2D-959B-A1756991E817|426||||||DISPOSITION EVENT||OBSERVATION|1972-01-01|1967-08-01||
TRIAL STUDY 134XCP|DS|E884C56C-1612-49CC-A594-B65E7B354842|427||||||OTHER EVENT||BASELINE|1970-01-02|1971-06-23||
TRIAL STUDY 134XCP|DS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF|428||||||DISPOSITION EVENT||INDUCTION TREATMENT|1965-09-15|1969-08-01||
TRIAL STUDY 134XCP|DS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E|429||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1960-05-29|1964-09-14||
TRIAL STUDY 134XCP|DS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604|430||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1962-09-24|1963-06-14||
TRIAL STUDY 134XCP|DS|0B140787-9458-4F66-B7E9-1FAFF239085E|431||||||OTHER EVENT||BLINDED TREATMENT|1969-05-17|1961-01-12||
TRIAL STUDY 134XCP|DS|FB91BADF-308B-4F6A-90D0-032E93E20C4A|432||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1964-08-06|1961-04-22||
TRIAL STUDY 134XCP|DS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC|433||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1963-12-20|1971-03-20||
TRIAL STUDY 134XCP|DS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1|434||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1970-06-11|1963-07-17||
TRIAL STUDY 134XCP|DS|3B583022-3A2C-4387-80A5-035E3FD111BD|435||||||OTHER EVENT||TREATMENT|1967-11-20|1968-12-23||
TRIAL STUDY 134XCP|DS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC|436||||||OTHER EVENT||SCREENING|1964-07-17|1970-01-06||
TRIAL STUDY 134XCP|DS|B5370AC4-3185-48DC-B1BC-A00AE8496783|437||||||DISPOSITION EVENT||BLINDED TREATMENT|1963-10-10|1971-08-17||
TRIAL STUDY 134XCP|DS|1112A903-1F2A-4583-BB9A-41DD206D5B4A|438||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1972-06-09|1967-03-05||
TRIAL STUDY 134XCP|DS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8|439||||||OTHER EVENT||RUN-IN|1961-09-21|1964-04-02||
TRIAL STUDY 134XCP|DS|D09F047E-E380-453B-875D-FF3C8C5EA839|440||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1965-06-19|1969-10-08||
TRIAL STUDY 134XCP|DS|E1B16559-B9CA-4B14-A77A-4AD546EF5262|441||||||PROTOCOL MILESTONE||BASELINE|1969-01-24|1968-06-20||
TRIAL STUDY 134XCP|DS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA|442||||||PROTOCOL MILESTONE||SCREENING|1963-09-08|1961-08-21||
TRIAL STUDY 134XCP|DS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2|443||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-06-03|1971-04-18||
TRIAL STUDY 134XCP|DS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8|444||||||OTHER EVENT||BASELINE|1965-03-23|1971-07-05||
TRIAL STUDY 134XCP|DS|44199000-F1B7-4187-9E5A-AA5F69E831C3|445||||||OTHER EVENT||BLINDED TREATMENT|1972-05-02|1972-09-04||
TRIAL STUDY 134XCP|DS|1D487F49-92DB-4132-BD95-1B8797594DE7|446||||||PROTOCOL MILESTONE||FOLLOW-UP|1968-04-03|1967-03-31||
TRIAL STUDY 134XCP|DS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5|447||||||DISPOSITION EVENT||TREATMENT|1973-07-18|1966-08-05||
TRIAL STUDY 134XCP|DS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF|448||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1968-01-11|1963-10-01||
TRIAL STUDY 134XCP|DS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5|449||||||PROTOCOL MILESTONE||SCREENING|1969-05-09|1963-03-12||
TRIAL STUDY 134XCP|DS|33233744-4E16-437D-852B-B5F2CCC94B1A|450||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1971-06-16|1960-01-23||
TRIAL STUDY 134XCP|DS|B27DC754-F6E2-41E3-9804-0F92AE0006B4|451||||||PROTOCOL MILESTONE||SCREENING|1970-11-24|1970-03-10||
TRIAL STUDY 134XCP|DS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6|452||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1972-05-13|1973-02-16||
TRIAL STUDY 134XCP|DS|BDE843D8-2F69-4542-BC47-D52302FD4898|453||||||OTHER EVENT||RUN-IN|1967-03-19|1970-07-15||
TRIAL STUDY 134XCP|DS|A8C8CB0C-C575-414C-BF1C-846361DB03BC|454||||||OTHER EVENT||CONTINUATION TREATMENT|1966-07-27|1961-03-24||
TRIAL STUDY 134XCP|DS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A|455||||||OTHER EVENT||WASHOUT|1961-07-21|1971-10-05||
TRIAL STUDY 134XCP|DS|86198851-0F45-45E0-A0CE-C50FEC078456|456||||||PROTOCOL MILESTONE||TREATMENT|1968-07-31|1969-04-06||
TRIAL STUDY 134XCP|DS|9CD28016-BED9-4159-9C1B-60821D74615B|457||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1963-01-07|1962-03-27||
TRIAL STUDY 134XCP|DS|BE578D25-C23E-416F-8A57-C901F7B58596|458||||||DISPOSITION EVENT||OBSERVATION|1963-01-22|1970-05-12||
TRIAL STUDY 134XCP|DS|A60D5FE6-26BA-487D-98E0-5F464305924C|459||||||DISPOSITION EVENT||OBSERVATION|1960-04-30|1965-03-31||
TRIAL STUDY 134XCP|DS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82|460||||||PROTOCOL MILESTONE||SCREENING|1964-06-21|1970-08-15||
TRIAL STUDY 134XCP|DS|89739AE0-A8B9-44DE-970E-9D679ED58C4F|461||||||OTHER EVENT||CONTINUATION TREATMENT|1970-06-05|1961-03-10||
TRIAL STUDY 134XCP|DS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8|462||||||PROTOCOL MILESTONE||OBSERVATION|1964-10-19|1963-04-12||
TRIAL STUDY 134XCP|DS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427|463||||||OTHER EVENT||BASELINE|1962-11-15|1971-07-17||
TRIAL STUDY 134XCP|DS|CED88848-769E-41C1-9ACD-99E45766D27B|464||||||DISPOSITION EVENT||SCREENING|1972-06-04|1972-11-25||
TRIAL STUDY 134XCP|DS|E7958F8B-D987-4929-993A-8960EB30A309|465||||||OTHER EVENT||FOLLOW-UP|1966-02-18|1966-11-30||
TRIAL STUDY 134XCP|DS|A633D973-B611-4014-A43E-C8C2D21DBFC2|466||||||OTHER EVENT||FOLLOW-UP|1962-06-09|1963-09-12||
TRIAL STUDY 134XCP|DS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7|467||||||OTHER EVENT||BLINDED TREATMENT|1962-03-06|1960-05-29||
TRIAL STUDY 134XCP|DS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6|468||||||PROTOCOL MILESTONE||SCREENING|1961-01-16|1963-05-13||
TRIAL STUDY 134XCP|DS|264AA652-A25E-43CE-A54F-6FEB54AB62F3|469||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1960-09-28|1969-05-06||
TRIAL STUDY 134XCP|DS|4DE042DC-2F1E-425C-BA36-F64A3493CE76|470||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1972-05-25|1969-02-07||
TRIAL STUDY 134XCP|DS|872942E9-A575-4929-9B21-D30DE51B367B|471||||||OTHER EVENT||INDUCTION TREATMENT|1963-12-02|1964-10-08||
TRIAL STUDY 134XCP|DS|628822F3-4983-44F8-B98D-7A35AAFF2962|472||||||DISPOSITION EVENT||SCREENING|1960-04-26|1967-01-09||
TRIAL STUDY 134XCP|DS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A|473||||||PROTOCOL MILESTONE||TREATMENT|1970-01-11|1963-03-21||
TRIAL STUDY 134XCP|DS|6045DFAB-0734-4E6D-A492-34BD613EC783|474||||||OTHER EVENT||BLINDED TREATMENT|1967-02-15|1963-06-21||
TRIAL STUDY 134XCP|DS|482F0519-E738-46DE-A5C4-4AC76B6E7011|475||||||OTHER EVENT||TREATMENT|1966-09-23|1967-05-02||
TRIAL STUDY 134XCP|DS|DFDD42F5-749C-4AF0-8351-780DB9614F61|476||||||DISPOSITION EVENT||BLINDED TREATMENT|1970-06-08|1962-01-15||
TRIAL STUDY 134XCP|DS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0|477||||||OTHER EVENT||RUN-IN|1969-05-22|1971-12-01||
TRIAL STUDY 134XCP|DS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099|478||||||OTHER EVENT||WASHOUT|1963-05-09|1970-05-18||
TRIAL STUDY 134XCP|DS|E0434C66-0F59-476F-9913-55766C4AED1B|479||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1973-03-23|1972-10-16||
TRIAL STUDY 134XCP|DS|60B57F98-61FF-4322-8084-7A536964F60A|480||||||OTHER EVENT||OBSERVATION|1962-12-01|1963-10-02||
TRIAL STUDY 134XCP|DS|C79CA198-24E2-4A76-8C32-F3AA973EA41E|481||||||OTHER EVENT||WASHOUT|1963-06-25|1964-11-15||
TRIAL STUDY 134XCP|DS|D250194D-9BBD-40D3-A13B-BBCEB53DB450|482||||||OTHER EVENT||CONTINUATION TREATMENT|1964-07-13|1962-10-02||
TRIAL STUDY 134XCP|DS|369AE0AF-8693-4363-9A6E-CD30567BD614|483||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1968-05-09|1961-05-26||
TRIAL STUDY 134XCP|DS|4497DB94-5B91-4169-9D73-73EE5C1D9B76|484||||||DISPOSITION EVENT||INDUCTION TREATMENT|1963-12-07|1968-03-16||
TRIAL STUDY 134XCP|DS|487D7E2D-6E7E-4A5E-ADC7-72B888746263|485||||||OTHER EVENT||TREATMENT|1972-12-15|1973-01-16||
TRIAL STUDY 134XCP|DS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895|486||||||PROTOCOL MILESTONE||SCREENING|1973-01-14|1969-10-02||
TRIAL STUDY 134XCP|DS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A|487||||||PROTOCOL MILESTONE||BASELINE|1964-10-28|1965-01-22||
TRIAL STUDY 134XCP|DS|8BF6E538-2F39-48E4-B115-AE1693843BBC|488||||||PROTOCOL MILESTONE||RUN-IN|1961-08-31|1972-06-22||
TRIAL STUDY 134XCP|DS|57F001BC-36EB-44AF-9487-373FA31B7311|489||||||DISPOSITION EVENT||TREATMENT|1971-08-27|1963-08-07||
TRIAL STUDY 134XCP|DS|3FBDC961-EB02-4B28-8672-2A0A0A33529E|490||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1963-05-10|1971-02-01||
TRIAL STUDY 134XCP|DS|1B524FC4-365B-4A16-A4D7-ED818C6E6086|491||||||DISPOSITION EVENT||FOLLOW-UP|1968-11-14|1964-04-29||
TRIAL STUDY 134XCP|DS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C|492||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1965-11-17|1963-12-23||
TRIAL STUDY 134XCP|DS|27671577-2C6D-429F-BED9-0EDAB15CCB33|493||||||PROTOCOL MILESTONE||OBSERVATION|1967-10-29|1961-11-20||
TRIAL STUDY 134XCP|DS|CD69750D-957B-405C-A397-AFA331D30535|494||||||OTHER EVENT||INDUCTION TREATMENT|1962-04-17|1971-06-12||
TRIAL STUDY 134XCP|DS|5BFDDFC2-7D15-4B01-8140-62376D160EF0|495||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1968-04-17|1964-08-21||
TRIAL STUDY 134XCP|DS|DEA8E573-2709-41F9-AB0D-8C39F5169B48|496||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1965-12-30|1973-04-29||
TRIAL STUDY 134XCP|DS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F|497||||||DISPOSITION EVENT||WASHOUT|1963-01-28|1965-03-09||
TRIAL STUDY 134XCP|DS|77CF8795-CFF5-40C6-A811-624972806A38|498||||||OTHER EVENT||RUN-IN|1970-07-29|1972-12-13||
TRIAL STUDY 134XCP|DS|D43B827C-D393-41D4-81C5-AACB1A7673A1|499||||||OTHER EVENT||TREATMENT|1960-09-24|1962-05-20||
TRIAL STUDY 134XCP|DS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161|500||||||DISPOSITION EVENT||SCREENING|1972-12-27|1967-05-11||
TRIAL STUDY 134XCP|DS|0671FB62-42B8-4882-93ED-0E11CFE07DE9|501||||||DISPOSITION EVENT||WASHOUT|1971-03-25|1972-11-14||
TRIAL STUDY 134XCP|DS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD|502||||||OTHER EVENT||SCREENING|1961-08-26|1961-10-04||
TRIAL STUDY 134XCP|DS|E9161164-3B91-4855-AFBA-12C6BD93F95F|503||||||PROTOCOL MILESTONE||SCREENING|1963-08-08|1964-03-14||
TRIAL STUDY 134XCP|DS|FBB66C13-05F5-4337-B34A-9900EB5F50F3|504||||||OTHER EVENT||OBSERVATION|1967-10-13|1960-05-31||
TRIAL STUDY 134XCP|DS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C|505||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1973-03-17|1964-03-20||
TRIAL STUDY 134XCP|DS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9|506||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1961-07-01|1962-02-12||
TRIAL STUDY 134XCP|DS|21223189-5527-4B3F-AFD5-21F77AC0DEBE|507||||||PROTOCOL MILESTONE||FOLLOW-UP|1964-03-04|1972-11-22||
TRIAL STUDY 134XCP|DS|CA6ECC17-3E3B-435C-A485-8612C267E52B|508||||||PROTOCOL MILESTONE||OBSERVATION|1971-02-21|1973-06-23||
TRIAL STUDY 134XCP|DS|BCB41507-87B3-4773-B1E5-AE039853DED0|509||||||OTHER EVENT||TREATMENT|1961-07-10|1971-06-26||
TRIAL STUDY 134XCP|DS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A|510||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1960-12-07|1968-12-15||
TRIAL STUDY 134XCP|DS|EC726B09-0B0F-4933-94F4-8941DF68EDE6|511||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1970-03-01|1973-01-22||
TRIAL STUDY 134XCP|DS|9F703096-9152-422E-AEAB-AD22F00863ED|512||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1967-06-02|1972-02-18||
TRIAL STUDY 134XCP|DS|57455593-8872-4B17-8B3F-8A02FE855290|513||||||PROTOCOL MILESTONE||BASELINE|1971-11-03|1960-01-19||
TRIAL STUDY 134XCP|DS|97F58005-7367-49DC-967B-FAD681B55DF8|514||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1964-11-12|1968-11-01||
TRIAL STUDY 134XCP|DS|83AC0828-3C22-4F7C-9D22-F044BB5B630D|515||||||DISPOSITION EVENT||SCREENING|1972-05-28|1971-08-10||
TRIAL STUDY 134XCP|DS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC|516||||||PROTOCOL MILESTONE||RUN-IN|1965-03-03|1964-11-19||
TRIAL STUDY 134XCP|DS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E|517||||||OTHER EVENT||OBSERVATION|1970-07-21|1968-06-28||
TRIAL STUDY 134XCP|DS|B386B813-1175-4421-9C86-F9AB597877FA|518||||||OTHER EVENT||BLINDED TREATMENT|1966-02-09|1969-06-02||
TRIAL STUDY 134XCP|DS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906|519||||||DISPOSITION EVENT||SCREENING|1961-09-27|1960-07-12||
TRIAL STUDY 134XCP|DS|7B33775D-1DFF-49A6-820E-7981F5C16AFF|520||||||PROTOCOL MILESTONE||SCREENING|1968-02-02|1971-01-22||
TRIAL STUDY 134XCP|DS|DC48DD03-B87E-422D-A2EE-D87342260E19|521||||||OTHER EVENT||OBSERVATION|1964-07-23|1970-04-26||
TRIAL STUDY 134XCP|DS|2E084441-61A3-4B8B-9050-A5D7B38CA978|522||||||OTHER EVENT||CONTINUATION TREATMENT|1963-04-05|1969-01-15||
TRIAL STUDY 134XCP|DS|601D563B-AA21-4859-A87E-B2068C1E3F53|523||||||OTHER EVENT||BASELINE|1969-06-21|1972-12-31||
TRIAL STUDY 134XCP|DS|D8FE5979-24C7-478F-8612-0102F28F5ADE|524||||||DISPOSITION EVENT||TREATMENT|1960-10-04|1972-02-25||
TRIAL STUDY 134XCP|DS|D275315F-D3C5-4260-8BD6-37DDB67262B0|525||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1962-05-30|1969-09-16||
TRIAL STUDY 134XCP|DS|34127CD2-378B-4335-AD4B-F305D0A21AF4|526||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1969-05-18|1970-12-04||
TRIAL STUDY 134XCP|DS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3|527||||||DISPOSITION EVENT||TREATMENT|1961-12-29|1966-07-01||
TRIAL STUDY 134XCP|DS|6EE04A90-681B-439E-9783-04B40A4AF240|528||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1972-09-15|1962-11-30||
TRIAL STUDY 134XCP|DS|A5C0B034-1226-40EE-87E3-D46A7342B550|529||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1970-04-23|1963-11-16||
TRIAL STUDY 134XCP|DS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865|530||||||DISPOSITION EVENT||BLINDED TREATMENT|1966-05-31|1971-08-06||
TRIAL STUDY 134XCP|DS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B|531||||||OTHER EVENT||BASELINE|1962-03-20|1963-11-30||
TRIAL STUDY 134XCP|DS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7|532||||||PROTOCOL MILESTONE||OBSERVATION|1963-03-08|1972-07-26||
TRIAL STUDY 134XCP|DS|D58A8C37-6659-4B00-8BED-256E8754F93C|533||||||OTHER EVENT||RUN-IN|1971-08-25|1971-01-13||
TRIAL STUDY 134XCP|DS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD|534||||||OTHER EVENT||BASELINE|1968-09-25|1961-09-22||
TRIAL STUDY 134XCP|DS|5440F45F-C220-46E7-8354-6AF34A003E5E|535||||||DISPOSITION EVENT||OBSERVATION|1971-06-02|1963-03-29||
TRIAL STUDY 134XCP|DS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C|536||||||OTHER EVENT||BASELINE|1964-05-08|1965-08-01||
TRIAL STUDY 134XCP|DS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5|537||||||OTHER EVENT||SCREENING|1966-05-19|1972-04-23||
TRIAL STUDY 134XCP|DS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59|538||||||OTHER EVENT||RUN-IN|1965-04-12|1970-07-01||
TRIAL STUDY 134XCP|DS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B|539||||||PROTOCOL MILESTONE||TREATMENT|1968-12-10|1966-01-04||
TRIAL STUDY 134XCP|DS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9|540||||||PROTOCOL MILESTONE||BASELINE|1971-10-24|1970-05-15||
TRIAL STUDY 134XCP|DS|1E9C7E41-8565-4C60-9EEB-814914081596|541||||||OTHER EVENT||SCREENING|1965-05-02|1963-08-17||
TRIAL STUDY 134XCP|DS|D7A008CF-5990-4D74-934A-A4DD3180EBD4|542||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1967-04-11|1970-06-18||
TRIAL STUDY 134XCP|DS|C168FA23-40EE-46D8-9A56-8B80490A0EFB|543||||||PROTOCOL MILESTONE||OBSERVATION|1973-08-19|1963-04-16||
TRIAL STUDY 134XCP|DS|215E4E69-70C3-493C-9D67-F717363E8138|544||||||OTHER EVENT||INDUCTION TREATMENT|1967-10-30|1964-05-08||
TRIAL STUDY 134XCP|DS|962CD4CA-AF22-42FB-ADB5-85F76850CA81|545||||||OTHER EVENT||CONTINUATION TREATMENT|1966-10-05|1967-11-29||
TRIAL STUDY 134XCP|DS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792|546||||||DISPOSITION EVENT||BLINDED TREATMENT|1962-12-15|1970-06-12||
TRIAL STUDY 134XCP|DS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD|547||||||PROTOCOL MILESTONE||TREATMENT|1966-03-29|1973-07-08||
TRIAL STUDY 134XCP|DS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7|548||||||OTHER EVENT||TREATMENT|1960-05-29|1962-11-04||
TRIAL STUDY 134XCP|DS|4A5A02C2-F875-4146-B58D-9E0E4F00527D|549||||||PROTOCOL MILESTONE||WASHOUT|1964-01-17|1965-10-03||
TRIAL STUDY 134XCP|DS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6|550||||||DISPOSITION EVENT||BLINDED TREATMENT|1969-03-25|1968-12-03||
TRIAL STUDY 134XCP|DS|859D9297-58D0-4740-899D-E7BEC931D419|551||||||OTHER EVENT||FOLLOW-UP|1962-02-21|1972-12-10||
TRIAL STUDY 134XCP|DS|A1E34C29-91C2-4C2B-942E-84CD6A10A056|552||||||DISPOSITION EVENT||OBSERVATION|1971-08-06|1962-03-14||
TRIAL STUDY 134XCP|DS|4E5FF284-E15A-421D-BC13-94655EEFE540|553||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1970-11-13|1972-02-16||
TRIAL STUDY 134XCP|DS|30BAB760-662A-41DF-9599-CBE0BC3A57D9|554||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1963-10-14|1965-12-30||
TRIAL STUDY 134XCP|DS|8747C2AB-18EB-430B-8E89-CF9183DBF322|555||||||DISPOSITION EVENT||WASHOUT|1964-03-13|1969-07-03||
TRIAL STUDY 134XCP|DS|5A0FF15D-E779-47BA-8D3C-247A0FA57854|556||||||DISPOSITION EVENT||SCREENING|1963-12-24|1970-05-04||
TRIAL STUDY 134XCP|DS|73260E60-6ADB-44DA-9A45-776B91F8B453|557||||||PROTOCOL MILESTONE||FOLLOW-UP|1966-01-09|1973-04-29||
TRIAL STUDY 134XCP|DS|7B64252E-9A08-4177-BFA9-45B0C0E53097|558||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1967-01-13|1963-09-09||
TRIAL STUDY 134XCP|DS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75|559||||||PROTOCOL MILESTONE||OBSERVATION|1966-03-15|1961-01-30||
TRIAL STUDY 134XCP|DS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3|560||||||OTHER EVENT||INDUCTION TREATMENT|1961-07-21|1972-08-01||
TRIAL STUDY 134XCP|DS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1|561||||||DISPOSITION EVENT||BLINDED TREATMENT|1965-09-13|1973-08-22||
TRIAL STUDY 134XCP|DS|1B0EE182-6729-4333-BB9B-5561CAB31D26|562||||||PROTOCOL MILESTONE||RUN-IN|1963-09-25|1971-07-06||
TRIAL STUDY 134XCP|DS|1F3AD620-4B16-4EFF-8F5A-45105841BE02|563||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1972-07-01|1969-04-26||
TRIAL STUDY 134XCP|DS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791|564||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1962-10-20|1972-10-25||
TRIAL STUDY 134XCP|DS|152147B0-6EAD-4124-8E1A-BD7707850B60|565||||||PROTOCOL MILESTONE||BASELINE|1964-07-12|1962-10-18||
TRIAL STUDY 134XCP|DS|3CCF019C-5663-4670-B2D1-EC01D6B58D06|566||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1967-06-03|1966-06-23||
TRIAL STUDY 134XCP|DS|6599D082-A8A0-412D-BBDF-CD786C581905|567||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1968-10-06|1971-08-26||
TRIAL STUDY 134XCP|DS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4|568||||||OTHER EVENT||BASELINE|1970-10-30|1966-03-15||
TRIAL STUDY 134XCP|DS|AAC3113C-793D-43F4-87E9-111246E03003|569||||||PROTOCOL MILESTONE||TREATMENT|1971-11-09|1965-01-30||
TRIAL STUDY 134XCP|DS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A|570||||||DISPOSITION EVENT||WASHOUT|1968-12-28|1965-12-11||
TRIAL STUDY 134XCP|DS|941A9CF9-872C-42CF-A409-129BE5A88520|571||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1961-11-04|1965-09-06||
TRIAL STUDY 134XCP|DS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38|572||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1962-03-19|1962-07-25||
TRIAL STUDY 134XCP|DS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE|573||||||OTHER EVENT||WASHOUT|1964-07-29|1966-01-19||
TRIAL STUDY 134XCP|DS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202|574||||||PROTOCOL MILESTONE||BASELINE|1964-11-02|1971-12-20||
TRIAL STUDY 134XCP|DS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D|575||||||PROTOCOL MILESTONE||BASELINE|1965-02-01|1971-01-24||
TRIAL STUDY 134XCP|DS|A4A5E66A-E65C-4234-8858-E69D04AB1593|576||||||DISPOSITION EVENT||INDUCTION TREATMENT|1972-12-04|1962-05-16||
TRIAL STUDY 134XCP|DS|0EA46DA5-4291-4585-9745-08BFA60BED3F|577||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1970-04-24|1972-02-22||
TRIAL STUDY 134XCP|DS|F54E494F-7EC2-41E7-A969-DF7151EA08E9|578||||||DISPOSITION EVENT||SCREENING|1971-08-23|1966-12-18||
TRIAL STUDY 134XCP|DS|3C4215F7-A7FA-4177-8B84-FD26FEB43039|579||||||PROTOCOL MILESTONE||FOLLOW-UP|1966-11-27|1966-07-05||
TRIAL STUDY 134XCP|DS|797C71A3-375E-466E-BDA8-A2828C9C45BB|580||||||OTHER EVENT||RUN-IN|1968-07-06|1960-07-18||
TRIAL STUDY 134XCP|DS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA|581||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1963-09-03|1971-12-12||
TRIAL STUDY 134XCP|DS|5617A5B9-AEE0-4118-9113-3755ED8E961A|582||||||OTHER EVENT||SCREENING|1963-08-18|1968-03-21||
TRIAL STUDY 134XCP|DS|7ECE0F95-910A-4FB3-9435-73805E498415|583||||||OTHER EVENT||CONTINUATION TREATMENT|1963-02-14|1969-08-30||
TRIAL STUDY 134XCP|DS|83EDB0FE-728D-453F-8DB2-7D44202EEB43|584||||||DISPOSITION EVENT||OBSERVATION|1964-07-11|1960-04-28||
TRIAL STUDY 134XCP|DS|35589D89-B019-4C5E-8A4B-BFA58E894A9C|585||||||DISPOSITION EVENT||SCREENING|1964-07-06|1970-02-28||
TRIAL STUDY 134XCP|DS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF|586||||||DISPOSITION EVENT||SCREENING|1960-02-16|1964-08-29||
TRIAL STUDY 134XCP|DS|21934F6E-8333-413B-931C-DF115519F394|587||||||OTHER EVENT||WASHOUT|1967-02-17|1971-07-20||
TRIAL STUDY 134XCP|DS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653|588||||||DISPOSITION EVENT||FOLLOW-UP|1973-06-08|1971-09-17||
TRIAL STUDY 134XCP|DS|E31F3DEB-BCA2-4660-935D-BAEBC4238866|589||||||OTHER EVENT||SCREENING|1962-02-14|1960-05-07||
TRIAL STUDY 134XCP|DS|8310989D-82CC-456C-965A-E38AC9EA073F|590||||||DISPOSITION EVENT||BASELINE|1962-06-15|1961-04-07||
TRIAL STUDY 134XCP|DS|826D8DC2-E407-481C-93D8-5169DBDF99C4|591||||||DISPOSITION EVENT||FOLLOW-UP|1969-03-10|1970-06-07||
TRIAL STUDY 134XCP|DS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3|592||||||DISPOSITION EVENT||BLINDED TREATMENT|1964-12-09|1964-12-13||
TRIAL STUDY 134XCP|DS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6|593||||||DISPOSITION EVENT||WASHOUT|1965-04-25|1966-10-19||
TRIAL STUDY 134XCP|DS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A|594||||||PROTOCOL MILESTONE||SCREENING|1967-11-19|1960-06-04||
TRIAL STUDY 134XCP|DS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D|595||||||OTHER EVENT||BASELINE|1970-09-05|1973-01-16||
TRIAL STUDY 134XCP|DS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772|596||||||DISPOSITION EVENT||WASHOUT|1960-07-05|1968-08-25||
TRIAL STUDY 134XCP|DS|B396F12E-7BF5-47CC-AFD1-1B679066B106|597||||||OTHER EVENT||BLINDED TREATMENT|1965-01-17|1964-11-24||
TRIAL STUDY 134XCP|DS|2936B26A-9A8D-4C28-90A7-6131837F255F|598||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1970-08-23|1970-08-04||
TRIAL STUDY 134XCP|DS|901A91DC-9EF3-4A20-A35D-9C426A5C640B|599||||||PROTOCOL MILESTONE||SCREENING|1961-12-15|1971-12-25||
TRIAL STUDY 134XCP|DS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4|600||||||OTHER EVENT||INDUCTION TREATMENT|1973-06-24|1966-07-21||
TRIAL STUDY 134XCP|DS|5A7F2C89-5398-4119-8EA0-B432FF8942A4|601||||||PROTOCOL MILESTONE||RUN-IN|1971-06-23|1963-09-18||
TRIAL STUDY 134XCP|DS|898FB78B-63D1-4ECE-B6B8-34750E958D93|602||||||OTHER EVENT||BASELINE|1961-04-01|1961-06-14||
TRIAL STUDY 134XCP|DS|AF1E7141-5390-4928-9F49-94E1C7464A63|603||||||OTHER EVENT||SCREENING|1963-10-23|1965-07-25||
TRIAL STUDY 134XCP|DS|2188CADE-EE6F-4F14-8049-5EDD72020185|604||||||OTHER EVENT||BASELINE|1972-12-21|1964-05-04||
TRIAL STUDY 134XCP|DS|DFF30783-4496-4134-8201-67C727683A7D|605||||||PROTOCOL MILESTONE||TREATMENT|1961-05-18|1964-01-19||
TRIAL STUDY 134XCP|DS|970170C0-8FF0-4D24-84E8-1195272D55C0|606||||||OTHER EVENT||FOLLOW-UP|1962-12-26|1971-09-01||
TRIAL STUDY 134XCP|DS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE|607||||||OTHER EVENT||BLINDED TREATMENT|1960-03-05|1960-06-19||
TRIAL STUDY 134XCP|DS|69CC47A3-DA90-4919-889E-E0008ED689FA|608||||||PROTOCOL MILESTONE||FOLLOW-UP|1964-02-22|1963-05-11||
TRIAL STUDY 134XCP|DS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577|609||||||DISPOSITION EVENT||SCREENING|1972-10-06|1973-05-25||
TRIAL STUDY 134XCP|DS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834|610||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1966-01-26|1961-12-22||
TRIAL STUDY 134XCP|DS|0281E055-F419-4BA2-89CE-23EC7428CDA0|611||||||PROTOCOL MILESTONE||SCREENING|1963-05-19|1967-06-21||
TRIAL STUDY 134XCP|DS|23CE1310-DBB3-4135-8E11-2A870CE42D50|612||||||PROTOCOL MILESTONE||WASHOUT|1972-03-25|1960-09-16||
TRIAL STUDY 134XCP|DS|CC80D8A2-7D71-428B-9599-C0D0312B8691|613||||||PROTOCOL MILESTONE||RUN-IN|1964-02-06|1962-06-17||
TRIAL STUDY 134XCP|DS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C|614||||||PROTOCOL MILESTONE||RUN-IN|1972-12-19|1973-02-22||
TRIAL STUDY 134XCP|DS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82|615||||||DISPOSITION EVENT||RUN-IN|1973-04-15|1968-03-08||
TRIAL STUDY 134XCP|DS|3D25A735-6298-4AF4-91CC-AE8D481DF552|616||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1966-01-14|1973-03-01||
TRIAL STUDY 134XCP|DS|C249E38B-B454-47D9-8D8B-E2F6A434BA21|617||||||DISPOSITION EVENT||BLINDED TREATMENT|1968-05-18|1963-05-24||
TRIAL STUDY 134XCP|DS|4540D569-1DD0-4984-89DB-6F9A391397FE|618||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1971-01-21|1962-10-26||
TRIAL STUDY 134XCP|DS|DC1D666E-4920-4B60-A520-D183BCDE0E85|619||||||OTHER EVENT||WASHOUT|1965-09-11|1969-03-01||
TRIAL STUDY 134XCP|DS|A015D12B-C03B-4371-8D1F-F03D60542BA7|620||||||DISPOSITION EVENT||SCREENING|1967-02-08|1965-04-11||
TRIAL STUDY 134XCP|DS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF|621||||||OTHER EVENT||INDUCTION TREATMENT|1970-09-21|1969-03-30||
TRIAL STUDY 134XCP|DS|34AC7973-686F-45A2-999A-1A36C7874F91|622||||||OTHER EVENT||BASELINE|1970-09-13|1961-11-15||
TRIAL STUDY 134XCP|DS|5AE66AC0-ECB6-49A2-859F-871B9A15E624|623||||||PROTOCOL MILESTONE||OBSERVATION|1968-09-11|1970-11-21||
TRIAL STUDY 134XCP|DS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22|624||||||DISPOSITION EVENT||OBSERVATION|1968-04-23|1960-07-07||
TRIAL STUDY 134XCP|DS|59A9826F-4C2F-482A-8888-F649544318BE|625||||||OTHER EVENT||RUN-IN|1961-03-27|1965-04-09||
TRIAL STUDY 134XCP|DS|B6E55A62-CF0B-4BC6-84DC-038F29518909|626||||||PROTOCOL MILESTONE||OBSERVATION|1960-01-02|1964-04-16||
TRIAL STUDY 134XCP|DS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7|627||||||DISPOSITION EVENT||BASELINE|1971-07-19|1962-10-13||
TRIAL STUDY 134XCP|DS|5577E914-C90D-4CC4-A7A8-D919C29A61D1|628||||||DISPOSITION EVENT||OBSERVATION|1961-02-07|1969-08-06||
TRIAL STUDY 134XCP|DS|2DBA8940-F59E-4A0D-8858-408D71DD9753|629||||||DISPOSITION EVENT||WASHOUT|1973-05-26|1962-10-23||
TRIAL STUDY 134XCP|DS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99|630||||||DISPOSITION EVENT||INDUCTION TREATMENT|1971-04-14|1970-09-29||
TRIAL STUDY 134XCP|DS|0250EC5D-B08F-4010-9653-95E20EDD0CCA|631||||||OTHER EVENT||CONTINUATION TREATMENT|1965-10-03|1968-08-08||
TRIAL STUDY 134XCP|DS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6|632||||||PROTOCOL MILESTONE||FOLLOW-UP|1970-10-21|1964-09-19||
TRIAL STUDY 134XCP|DS|140FFC83-72C9-4BD4-AA44-C98CA42147F3|633||||||OTHER EVENT||BLINDED TREATMENT|1970-04-05|1968-02-23||
TRIAL STUDY 134XCP|DS|7BAC399A-0523-476E-A294-C57309E573AF|634||||||PROTOCOL MILESTONE||TREATMENT|1966-02-02|1968-10-15||
TRIAL STUDY 134XCP|DS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5|635||||||DISPOSITION EVENT||TREATMENT|1967-06-30|1970-07-31||
TRIAL STUDY 134XCP|DS|0F180E62-F840-490F-8EB3-F7DDB7132401|636||||||PROTOCOL MILESTONE||WASHOUT|1965-12-29|1961-01-12||
TRIAL STUDY 134XCP|DS|80E7A428-CDDE-453F-B7D1-1B282A1835BF|637||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1973-02-01|1963-01-19||
TRIAL STUDY 134XCP|DS|F1D265C4-B975-4E74-9545-122A10FE100F|638||||||OTHER EVENT||CONTINUATION TREATMENT|1969-08-02|1972-08-02||
TRIAL STUDY 134XCP|DS|7A272C35-DB2C-429D-AF31-CC7386DC8F07|639||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1961-03-22|1967-02-13||
TRIAL STUDY 134XCP|DS|FBF95CF9-933D-406A-8D67-B1F643C5F554|640||||||OTHER EVENT||TREATMENT|1964-10-12|1965-08-26||
TRIAL STUDY 134XCP|DS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09|641||||||PROTOCOL MILESTONE||SCREENING|1965-10-07|1963-01-30||
TRIAL STUDY 134XCP|DS|391D2418-5359-457B-AEC5-6A48DE04DAFD|642||||||OTHER EVENT||TREATMENT|1966-12-28|1963-10-28||
TRIAL STUDY 134XCP|DS|68F706F0-2F0B-4D50-B15C-2DFDD186112E|643||||||DISPOSITION EVENT||BLINDED TREATMENT|1960-07-29|1966-10-28||
TRIAL STUDY 134XCP|DS|E8D4AACE-0832-482D-8266-96B7423F9459|644||||||DISPOSITION EVENT||BASELINE|1962-08-12|1962-04-14||
TRIAL STUDY 134XCP|DS|F358E69F-9B9A-4637-9063-B8FECFF000B2|645||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1961-09-19|1964-11-05||
TRIAL STUDY 134XCP|DS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44|646||||||DISPOSITION EVENT||SCREENING|1960-10-29|1960-05-04||
TRIAL STUDY 134XCP|DS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4|647||||||DISPOSITION EVENT||SCREENING|1960-05-23|1963-12-10||
TRIAL STUDY 134XCP|DS|586B4529-9808-4205-B3D6-5C4A1DAFA922|648||||||OTHER EVENT||FOLLOW-UP|1962-02-03|1972-03-31||
TRIAL STUDY 134XCP|DS|54685EFC-EE92-4591-B059-24145A3E6D69|649||||||DISPOSITION EVENT||SCREENING|1972-01-20|1965-01-15||
TRIAL STUDY 134XCP|DS|7BD32505-61D5-4862-8896-B3E41D3EE779|650||||||DISPOSITION EVENT||BASELINE|1960-12-17|1970-03-27||
TRIAL STUDY 134XCP|DS|3461C227-E30F-482B-B404-026FE0CA3549|651||||||DISPOSITION EVENT||FOLLOW-UP|1970-05-19|1962-05-25||
TRIAL STUDY 134XCP|DS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F|652||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1972-06-29|1968-06-03||
TRIAL STUDY 134XCP|DS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4|653||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1960-07-06|1967-08-28||
TRIAL STUDY 134XCP|DS|C7C91F63-87B7-4E62-B5F3-39979F74E955|654||||||OTHER EVENT||BLINDED TREATMENT|1969-03-26|1968-06-16||
TRIAL STUDY 134XCP|DS|D6659F53-6DF6-4F88-BF9A-160E2D057028|655||||||OTHER EVENT||FOLLOW-UP|1972-08-23|1971-03-15||
TRIAL STUDY 134XCP|DS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286|656||||||OTHER EVENT||CONTINUATION TREATMENT|1969-08-21|1967-02-05||
TRIAL STUDY 134XCP|DS|91B36C93-3ADF-4570-B355-BC81B097EEFC|657||||||OTHER EVENT||WASHOUT|1968-04-09|1966-03-23||
TRIAL STUDY 134XCP|DS|ADD0DDE5-166F-4C20-B3C3-31B131509771|658||||||OTHER EVENT||OPEN LABEL TREATMENT|1969-12-21|1964-01-15||
TRIAL STUDY 134XCP|DS|4265CC9E-26AF-4A14-B9AA-04A246E2523C|659||||||OTHER EVENT||OBSERVATION|1972-05-22|1971-05-07||
TRIAL STUDY 134XCP|DS|96F268D3-7441-415C-95C9-A6B70C1718D5|660||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1970-03-17|1960-04-06||
TRIAL STUDY 134XCP|DS|15D32D1F-AEE2-474C-956E-461FB087D7B0|661||||||PROTOCOL MILESTONE||TREATMENT|1960-02-10|1960-01-03||
TRIAL STUDY 134XCP|DS|DB42C81A-D644-455D-9D95-42131EF2BFE5|662||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1966-11-07|1960-01-02||
TRIAL STUDY 134XCP|DS|4B01CC59-51D3-4499-9AB1-DF446006CB8D|663||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1971-07-09|1960-04-08||
TRIAL STUDY 134XCP|DS|B69774FC-1151-45DD-B329-6C21C2F29603|664||||||OTHER EVENT||WASHOUT|1962-08-29|1961-01-04||
TRIAL STUDY 134XCP|DS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5|665||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1971-07-09|1966-09-19||
TRIAL STUDY 134XCP|DS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9|666||||||PROTOCOL MILESTONE||SCREENING|1966-09-21|1967-04-01||
TRIAL STUDY 134XCP|DS|674B4474-6D52-4DE2-8342-EDB28F577BB5|667||||||PROTOCOL MILESTONE||SCREENING|1967-12-20|1964-03-30||
TRIAL STUDY 134XCP|DS|AF634AD4-086A-47EE-A5DB-A4B6833356C7|668||||||DISPOSITION EVENT||TREATMENT|1968-06-24|1962-01-14||
TRIAL STUDY 134XCP|DS|89298058-EB86-4892-97D6-1B87277DF7FC|669||||||PROTOCOL MILESTONE||TREATMENT|1962-09-29|1961-03-24||
TRIAL STUDY 134XCP|DS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5|670||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1970-11-01|1963-10-30||
TRIAL STUDY 134XCP|DS|D5235188-810B-431F-A6EF-E50DAA57F5E7|671||||||DISPOSITION EVENT||BASELINE|1965-10-20|1967-10-02||
TRIAL STUDY 134XCP|DS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1|672||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1972-04-26|1961-04-28||
TRIAL STUDY 134XCP|DS|E3BB136E-0913-43FB-B760-CBE939F0C4D2|673||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1971-07-08|1965-11-16||
TRIAL STUDY 134XCP|DS|60C25341-42CE-4532-8F99-25B8305C4ED5|674||||||OTHER EVENT||RUN-IN|1972-03-10|1969-09-06||
TRIAL STUDY 134XCP|DS|42B54D88-E5B5-4828-958B-4B64F07E34B3|675||||||OTHER EVENT||OPEN LABEL TREATMENT|1966-06-24|1969-05-04||
TRIAL STUDY 134XCP|DS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6|676||||||DISPOSITION EVENT||BLINDED TREATMENT|1961-03-05|1964-09-08||
TRIAL STUDY 134XCP|DS|1FD985ED-A573-4A00-8902-214A7F182F28|677||||||OTHER EVENT||INDUCTION TREATMENT|1965-06-21|1964-05-10||
TRIAL STUDY 134XCP|DS|A2FD338A-F994-4399-BD02-99CB299F768E|678||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1965-05-07|1965-07-06||
TRIAL STUDY 134XCP|DS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E|679||||||OTHER EVENT||INDUCTION TREATMENT|1970-05-22|1966-11-03||
TRIAL STUDY 134XCP|DS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C|680||||||OTHER EVENT||CONTINUATION TREATMENT|1962-09-29|1962-06-03||
TRIAL STUDY 134XCP|DS|A8821AEE-49EB-4687-BB63-361BC3B8B182|681||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1962-09-12|1971-12-15||
TRIAL STUDY 134XCP|DS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1|682||||||OTHER EVENT||CONTINUATION TREATMENT|1972-11-23|1968-09-13||
TRIAL STUDY 134XCP|DS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC|683||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1963-04-18|1971-12-13||
TRIAL STUDY 134XCP|DS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B|684||||||OTHER EVENT||OPEN LABEL TREATMENT|1971-08-28|1969-02-20||
TRIAL STUDY 134XCP|DS|E711C534-E58F-4B41-95CC-24E938D89B61|685||||||DISPOSITION EVENT||FOLLOW-UP|1973-03-16|1970-10-06||
TRIAL STUDY 134XCP|DS|83938342-C01F-491A-84A7-F85D327F112D|686||||||OTHER EVENT||RUN-IN|1962-01-29|1967-07-25||
TRIAL STUDY 134XCP|DS|731665AB-4418-4943-BFC5-D78F03C8D423|687||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1964-11-29|1969-11-28||
TRIAL STUDY 134XCP|DS|3E337B9F-D718-4FE6-83D8-E05BC77CA872|688||||||PROTOCOL MILESTONE||BASELINE|1964-05-03|1971-04-10||
TRIAL STUDY 134XCP|DS|D5243E6E-2521-4331-ABFB-75112D06F771|689||||||PROTOCOL MILESTONE||FOLLOW-UP|1971-11-27|1971-07-07||
TRIAL STUDY 134XCP|DS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC|690||||||DISPOSITION EVENT||BLINDED TREATMENT|1963-04-24|1968-10-22||
TRIAL STUDY 134XCP|DS|5B3E406E-F2A5-4F25-8271-DC1FABA40138|691||||||OTHER EVENT||RUN-IN|1973-07-06|1962-12-03||
TRIAL STUDY 134XCP|DS|D5262627-52D7-42F5-B4BA-D7E6FA243959|692||||||OTHER EVENT||TREATMENT|1966-02-12|1966-03-25||
TRIAL STUDY 134XCP|DS|C550278D-F171-42D0-8C34-D60824A3FE98|693||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1960-09-01|1973-04-09||
TRIAL STUDY 134XCP|DS|5E76262E-FE1E-40C9-B147-3C792F768F48|694||||||OTHER EVENT||SCREENING|1969-06-14|1966-07-09||
TRIAL STUDY 134XCP|DS|2F21921D-D18C-43EE-A39E-91A93B262B8C|695||||||OTHER EVENT||TREATMENT|1963-02-25|1970-09-16||
TRIAL STUDY 134XCP|DS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC|696||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1963-09-03|1961-10-09||
TRIAL STUDY 134XCP|DS|55985646-0224-4442-90C5-EFEDF990E88C|697||||||PROTOCOL MILESTONE||RUN-IN|1973-05-04|1965-07-01||
TRIAL STUDY 134XCP|DS|86509C90-3C57-4755-A06F-79C620779371|698||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1960-06-16|1963-03-30||
TRIAL STUDY 134XCP|DS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3|699||||||OTHER EVENT||RUN-IN|1961-06-16|1963-07-29||
TRIAL STUDY 134XCP|DS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1|700||||||OTHER EVENT||INDUCTION TREATMENT|1962-10-01|1962-08-10||
TRIAL STUDY 134XCP|DS|0FFBFF7C-7C64-411E-8D07-C959F0886023|701||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1969-02-13|1963-01-22||
TRIAL STUDY 134XCP|DS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51|702||||||PROTOCOL MILESTONE||OBSERVATION|1963-06-02|1962-11-14||
TRIAL STUDY 134XCP|DS|5DC5F780-264A-4EB1-BEA5-28209D416FEB|703||||||OTHER EVENT||TREATMENT|1971-07-23|1961-06-19||
TRIAL STUDY 134XCP|DS|DDBCA084-DD05-4FA0-9083-7CD31CECA420|704||||||OTHER EVENT||BASELINE|1969-08-07|1966-09-07||
TRIAL STUDY 134XCP|DS|65A5AAA6-A817-45F8-9BA8-584E9627AB26|705||||||DISPOSITION EVENT||SCREENING|1972-01-04|1965-10-04||
TRIAL STUDY 134XCP|DS|854AD9A5-A869-41C7-9AF0-43383CE64B86|706||||||OTHER EVENT||TREATMENT|1962-01-26|1967-02-16||
TRIAL STUDY 134XCP|DS|008F02C8-B28A-490E-A77A-F32584DA06FA|707||||||PROTOCOL MILESTONE||OBSERVATION|1962-07-19|1960-09-25||
TRIAL STUDY 134XCP|DS|7C06549D-596C-4C47-BD0B-119DF6CD67AC|708||||||DISPOSITION EVENT||INDUCTION TREATMENT|1963-12-25|1972-01-24||
TRIAL STUDY 134XCP|DS|39A00D93-61B9-44C5-9672-005A1F9A93EB|709||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1970-06-03|1973-06-10||
TRIAL STUDY 134XCP|DS|71B78EFA-AE7A-4248-9A59-63885131F1D1|710||||||PROTOCOL MILESTONE||OBSERVATION|1964-01-04|1963-05-25||
TRIAL STUDY 134XCP|DS|CE28B885-422E-471D-895C-DE8F41CD9FE9|711||||||PROTOCOL MILESTONE||SCREENING|1967-06-03|1968-11-17||
TRIAL STUDY 134XCP|DS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5|712||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1972-04-03|1970-08-28||
TRIAL STUDY 134XCP|DS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982|713||||||PROTOCOL MILESTONE||RUN-IN|1973-05-22|1963-11-04||
TRIAL STUDY 134XCP|DS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862|714||||||DISPOSITION EVENT||BLINDED TREATMENT|1965-04-19|1962-05-29||
TRIAL STUDY 134XCP|DS|3AA56307-0D09-4C82-91B6-717A7C503EFE|715||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1966-02-13|1962-03-18||
TRIAL STUDY 134XCP|DS|811AE318-625A-4913-8B18-2D318AF04EAC|716||||||OTHER EVENT||FOLLOW-UP|1960-09-19|1967-01-04||
TRIAL STUDY 134XCP|DS|E8F0AF72-5DB4-41D5-814E-5E280A027E94|717||||||PROTOCOL MILESTONE||BASELINE|1963-01-22|1962-10-26||
TRIAL STUDY 134XCP|DS|3B726736-01B3-4A69-ABFB-C6255E341E69|718||||||OTHER EVENT||FOLLOW-UP|1964-12-10|1966-12-28||
TRIAL STUDY 134XCP|DS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0|719||||||PROTOCOL MILESTONE||OBSERVATION|1967-08-25|1968-09-05||
TRIAL STUDY 134XCP|DS|0535EF31-5388-4CC0-8567-44F4C20975EC|720||||||DISPOSITION EVENT||FOLLOW-UP|1968-08-25|1967-05-12||
TRIAL STUDY 134XCP|DS|F149BD98-0802-4C18-8599-426C5258D513|721||||||PROTOCOL MILESTONE||OBSERVATION|1961-04-07|1969-07-26||
TRIAL STUDY 134XCP|DS|5A31D035-90D2-4BD0-AE08-839862D6E0DF|722||||||DISPOSITION EVENT||TREATMENT|1968-10-20|1965-01-27||
TRIAL STUDY 134XCP|DS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49|723||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1970-08-10|1968-01-25||
TRIAL STUDY 134XCP|DS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355|724||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1966-03-14|1970-05-09||
TRIAL STUDY 134XCP|DS|9C9398A4-38BC-40A7-880D-4549A676F69B|725||||||DISPOSITION EVENT||SCREENING|1973-03-18|1965-02-19||
TRIAL STUDY 134XCP|DS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549|726||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1965-08-27|1966-12-10||
TRIAL STUDY 134XCP|DS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824|727||||||DISPOSITION EVENT||RUN-IN|1963-08-30|1971-09-25||
TRIAL STUDY 134XCP|DS|1E049F70-8E29-458F-BF37-13450BC9227E|728||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1969-02-07|1967-12-02||
TRIAL STUDY 134XCP|DS|7A612F0F-943A-4283-9A11-B8E8E8D68D66|729||||||PROTOCOL MILESTONE||TREATMENT|1967-02-27|1965-08-16||
TRIAL STUDY 134XCP|DS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B|730||||||OTHER EVENT||TREATMENT|1965-05-28|1961-08-19||
TRIAL STUDY 134XCP|DS|8C86A799-2717-46E8-99C2-76D11AAB54D7|731||||||OTHER EVENT||OBSERVATION|1963-06-15|1970-06-23||
TRIAL STUDY 134XCP|DS|727807A8-A180-4589-A553-E3C82E1D3CF2|732||||||PROTOCOL MILESTONE||FOLLOW-UP|1967-01-14|1966-05-06||
TRIAL STUDY 134XCP|DS|BFFB5321-5FC7-4465-8579-D75865306359|733||||||OTHER EVENT||OPEN LABEL TREATMENT|1961-05-05|1967-12-07||
TRIAL STUDY 134XCP|DS|12F9A745-F76D-4222-B37E-22AF93981ECE|734||||||PROTOCOL MILESTONE||BASELINE|1967-07-27|1969-07-30||
TRIAL STUDY 134XCP|DS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297|735||||||OTHER EVENT||INDUCTION TREATMENT|1969-07-09|1970-04-06||
TRIAL STUDY 134XCP|DS|37693A38-D8A0-4313-A4D1-56E282579636|736||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1961-05-21|1960-03-27||
TRIAL STUDY 134XCP|DS|5C48E0BB-FD52-47F5-8759-6126ECB47B80|737||||||OTHER EVENT||OBSERVATION|1964-09-10|1963-05-27||
TRIAL STUDY 134XCP|DS|5B420A5A-DB2C-48D2-8E9B-97639F49F182|738||||||DISPOSITION EVENT||BASELINE|1964-09-19|1966-07-10||
TRIAL STUDY 134XCP|DS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019|739||||||PROTOCOL MILESTONE||BASELINE|1963-05-30|1966-04-22||
TRIAL STUDY 134XCP|DS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F|740||||||OTHER EVENT||RUN-IN|1969-10-07|1962-06-22||
TRIAL STUDY 134XCP|DS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB|741||||||OTHER EVENT||INDUCTION TREATMENT|1965-12-17|1968-04-25||
TRIAL STUDY 134XCP|DS|9B95CE9F-E755-463A-92EC-07A55EE8A58F|742||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1973-08-05|1966-10-18||
TRIAL STUDY 134XCP|DS|ED388A78-3B06-4529-861A-0174E7F345C2|743||||||DISPOSITION EVENT||BASELINE|1963-09-14|1966-06-03||
TRIAL STUDY 134XCP|DS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA|744||||||OTHER EVENT||BASELINE|1972-04-06|1970-11-01||
TRIAL STUDY 134XCP|DS|172AB680-362D-488C-9DF1-E1C8E386980D|745||||||PROTOCOL MILESTONE||OBSERVATION|1966-11-16|1963-09-02||
TRIAL STUDY 134XCP|DS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78|746||||||DISPOSITION EVENT||BLINDED TREATMENT|1962-06-17|1973-04-06||
TRIAL STUDY 134XCP|DS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC|747||||||DISPOSITION EVENT||INDUCTION TREATMENT|1966-05-22|1969-05-30||
TRIAL STUDY 134XCP|DS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB|748||||||OTHER EVENT||WASHOUT|1963-01-19|1961-11-30||
TRIAL STUDY 134XCP|DS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE|749||||||OTHER EVENT||BASELINE|1961-07-19|1973-07-26||
TRIAL STUDY 134XCP|DS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3|750||||||OTHER EVENT||BLINDED TREATMENT|1970-05-03|1967-07-16||
TRIAL STUDY 134XCP|DS|740D80F1-8BD5-4409-8087-E48F94363362|751||||||OTHER EVENT||FOLLOW-UP|1960-04-07|1961-09-04||
TRIAL STUDY 134XCP|DS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87|752||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-07-27|1970-12-07||
TRIAL STUDY 134XCP|DS|12AD3838-F986-4A27-8AEE-59C387988B0F|753||||||PROTOCOL MILESTONE||FOLLOW-UP|1968-10-27|1965-12-29||
TRIAL STUDY 134XCP|DS|441F1A21-6350-478A-9719-75B053182B78|754||||||OTHER EVENT||OBSERVATION|1962-10-04|1962-05-19||
TRIAL STUDY 134XCP|DS|A69520E2-01A5-4CBC-AFC9-00324531779F|755||||||DISPOSITION EVENT||OBSERVATION|1968-10-26|1961-09-25||
TRIAL STUDY 134XCP|DS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7|756||||||PROTOCOL MILESTONE||WASHOUT|1965-09-09|1965-07-12||
TRIAL STUDY 134XCP|DS|C361B153-4623-4F03-9D81-8316B1046F35|757||||||OTHER EVENT||BASELINE|1971-12-19|1970-05-11||
TRIAL STUDY 134XCP|DS|8FF0A93C-26D1-49E9-853F-B063A958FE1E|758||||||OTHER EVENT||INDUCTION TREATMENT|1963-10-20|1971-10-15||
TRIAL STUDY 134XCP|DS|31D8814B-5542-4540-B955-24410D42F1EF|759||||||DISPOSITION EVENT||FOLLOW-UP|1962-07-06|1963-02-06||
TRIAL STUDY 134XCP|DS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A|760||||||DISPOSITION EVENT||FOLLOW-UP|1965-03-19|1972-05-16||
TRIAL STUDY 134XCP|DS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C|761||||||OTHER EVENT||CONTINUATION TREATMENT|1963-12-03|1967-08-29||
TRIAL STUDY 134XCP|DS|15BFC17A-2F55-441A-AB99-76D270D62367|762||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1960-12-18|1963-05-16||
TRIAL STUDY 134XCP|DS|CA231D77-1A1F-49F3-8172-06709A1330B7|763||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1964-12-22|1965-05-21||
TRIAL STUDY 134XCP|DS|7A4D6074-E870-40E8-B567-D069BCB7DA9F|764||||||OTHER EVENT||BLINDED TREATMENT|1972-03-31|1963-10-11||
TRIAL STUDY 134XCP|DS|3DDD2A7E-B955-424B-B485-54E81D0E0699|765||||||OTHER EVENT||BLINDED TREATMENT|1973-08-15|1972-09-19||
TRIAL STUDY 134XCP|DS|D6757E79-3104-468E-BADC-8CCB51BFAE87|766||||||DISPOSITION EVENT||BLINDED TREATMENT|1971-04-20|1969-11-03||
TRIAL STUDY 134XCP|DS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E|767||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1963-11-23|1969-06-04||
TRIAL STUDY 134XCP|DS|FBAA59F4-154C-40CC-B740-A87769BFEC45|768||||||DISPOSITION EVENT||BASELINE|1970-08-30|1969-09-14||
TRIAL STUDY 134XCP|DS|9A9E638B-426B-4F3E-8363-50DC2617FD63|769||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1965-02-05|1969-11-08||
TRIAL STUDY 134XCP|DS|9995CD08-2650-4711-8F04-E41183E28B21|770||||||DISPOSITION EVENT||TREATMENT|1960-09-13|1969-10-31||
TRIAL STUDY 134XCP|DS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A|771||||||DISPOSITION EVENT||BASELINE|1963-06-21|1967-02-22||
TRIAL STUDY 134XCP|DS|DE805225-C632-46E6-B673-DA0D864D47F7|772||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1971-11-19|1972-10-28||
TRIAL STUDY 134XCP|DS|9C921E89-706F-46E8-ADE3-A806289D43A5|773||||||DISPOSITION EVENT||OBSERVATION|1970-07-19|1964-10-30||
TRIAL STUDY 134XCP|DS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB|774||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1972-09-23|1961-02-28||
TRIAL STUDY 134XCP|DS|17C2A52E-1232-4CBB-A809-9DC2C863366A|775||||||OTHER EVENT||TREATMENT|1967-09-13|1961-10-11||
TRIAL STUDY 134XCP|DS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26|776||||||DISPOSITION EVENT||RUN-IN|1970-04-06|1967-07-02||
TRIAL STUDY 134XCP|DS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B|777||||||PROTOCOL MILESTONE||RUN-IN|1963-07-05|1972-07-26||
TRIAL STUDY 134XCP|DS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33|778||||||PROTOCOL MILESTONE||RUN-IN|1970-08-18|1960-04-05||
TRIAL STUDY 134XCP|DS|585A17D7-12A3-40C8-811F-339497B9D09C|779||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1961-06-13|1962-07-26||
TRIAL STUDY 134XCP|DS|D777661E-DF03-4221-88CC-34EB805EF5DB|780||||||OTHER EVENT||BASELINE|1965-11-01|1962-02-07||
TRIAL STUDY 134XCP|DS|67828FC5-94DE-4A68-83DE-F86AA8F86D72|781||||||PROTOCOL MILESTONE||SCREENING|1960-05-31|1973-06-05||
TRIAL STUDY 134XCP|DS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC|782||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1970-01-20|1963-07-30||
TRIAL STUDY 134XCP|DS|650E5DFA-08CC-413C-B43D-070E61353E6E|783||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1962-11-09|1967-06-09||
TRIAL STUDY 134XCP|DS|71716F05-3ABE-4A2A-B9DD-2201A63087ED|784||||||OTHER EVENT||SCREENING|1966-10-02|1970-11-13||
TRIAL STUDY 134XCP|DS|EF9208B0-4DF0-4029-AB67-8F87662D3E90|785||||||PROTOCOL MILESTONE||RUN-IN|1965-06-08|1972-06-25||
TRIAL STUDY 134XCP|DS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5|786||||||PROTOCOL MILESTONE||WASHOUT|1970-04-30|1968-10-25||
TRIAL STUDY 134XCP|DS|25580765-CB09-4BE3-8DED-C0068C69E9C4|787||||||PROTOCOL MILESTONE||RUN-IN|1962-06-19|1967-11-02||
TRIAL STUDY 134XCP|DS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3|788||||||OTHER EVENT||INDUCTION TREATMENT|1971-01-30|1968-02-05||
TRIAL STUDY 134XCP|DS|A902F087-3BF4-4387-80F9-DDCDDCE1813E|789||||||DISPOSITION EVENT||BLINDED TREATMENT|1962-12-14|1962-08-29||
TRIAL STUDY 134XCP|DS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9|790||||||OTHER EVENT||OPEN LABEL TREATMENT|1964-12-27|1962-03-17||
TRIAL STUDY 134XCP|DS|415F9206-A793-437C-B227-BD245DBF40AB|791||||||DISPOSITION EVENT||OBSERVATION|1964-06-30|1963-12-09||
TRIAL STUDY 134XCP|DS|C580BA02-D031-4875-AC02-347AA65C4C6C|792||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1961-10-08|1962-05-12||
TRIAL STUDY 134XCP|DS|4DD6944D-662E-4C9A-A663-601B657BCF5E|793||||||PROTOCOL MILESTONE||SCREENING|1960-08-23|1964-11-03||
TRIAL STUDY 134XCP|DS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB|794||||||OTHER EVENT||CONTINUATION TREATMENT|1970-02-03|1960-09-14||
TRIAL STUDY 134XCP|DS|69A130F1-44A1-4091-BF0C-FF8087CC9940|795||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1971-12-08|1971-11-09||
TRIAL STUDY 134XCP|DS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF|796||||||DISPOSITION EVENT||FOLLOW-UP|1967-01-13|1968-12-14||
TRIAL STUDY 134XCP|DS|96C60715-2EDE-40FD-B41C-ECD1E5065C81|797||||||DISPOSITION EVENT||TREATMENT|1965-10-05|1965-05-17||
TRIAL STUDY 134XCP|DS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D|798||||||DISPOSITION EVENT||INDUCTION TREATMENT|1965-11-18|1971-10-31||
TRIAL STUDY 134XCP|DS|8452DD7A-4DC9-4BDF-B670-AE5B49292805|799||||||PROTOCOL MILESTONE||SCREENING|1969-07-13|1968-02-17||
TRIAL STUDY 134XCP|DS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E|800||||||OTHER EVENT||BLINDED TREATMENT|1968-01-22|1971-07-30||
TRIAL STUDY 134XCP|DS|30108497-140B-499E-8924-8BFCDC57457A|801||||||OTHER EVENT||RUN-IN|1969-03-11|1970-11-24||
TRIAL STUDY 134XCP|DS|5FFEF358-5014-497F-A091-6EF27A1BCF7D|802||||||OTHER EVENT||OPEN LABEL TREATMENT|1965-02-24|1960-04-20||
TRIAL STUDY 134XCP|DS|9DFBE459-22E4-4BA7-A993-AC06D6644562|803||||||PROTOCOL MILESTONE||SCREENING|1970-11-17|1969-01-02||
TRIAL STUDY 134XCP|DS|850B35FA-69C7-44AD-A471-964C59C4CFD8|804||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1972-09-07|1970-10-07||
TRIAL STUDY 134XCP|DS|981B890E-1257-4F04-A974-6006401F78CC|805||||||OTHER EVENT||BASELINE|1966-02-17|1966-02-03||
TRIAL STUDY 134XCP|DS|52FF8D96-64AD-498D-8B28-3DDD015796E3|806||||||PROTOCOL MILESTONE||OBSERVATION|1967-08-05|1960-03-09||
TRIAL STUDY 134XCP|DS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40|807||||||PROTOCOL MILESTONE||WASHOUT|1970-02-17|1964-09-12||
TRIAL STUDY 134XCP|DS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD|808||||||PROTOCOL MILESTONE||FOLLOW-UP|1961-10-16|1961-10-11||
TRIAL STUDY 134XCP|DS|CD65CBB8-D056-4738-93A8-FF465534961B|809||||||OTHER EVENT||BLINDED TREATMENT|1963-04-09|1971-08-20||
TRIAL STUDY 134XCP|DS|7F014394-ABE2-45F8-891F-2DE808762532|810||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1969-05-26|1969-08-10||
TRIAL STUDY 134XCP|DS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4|811||||||PROTOCOL MILESTONE||RUN-IN|1960-09-08|1969-08-01||
TRIAL STUDY 134XCP|DS|FB781158-BB8A-4A75-BD55-00D6A5C72720|812||||||OTHER EVENT||CONTINUATION TREATMENT|1964-01-18|1965-11-22||
TRIAL STUDY 134XCP|DS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0|813||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1971-07-22|1962-09-14||
TRIAL STUDY 134XCP|DS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA|814||||||OTHER EVENT||RUN-IN|1962-09-07|1969-12-10||
TRIAL STUDY 134XCP|DS|505A1BB6-135A-4839-BB9E-6DD37F49DC45|815||||||PROTOCOL MILESTONE||BASELINE|1965-07-23|1971-02-12||
TRIAL STUDY 134XCP|DS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F|816||||||DISPOSITION EVENT||BLINDED TREATMENT|1964-05-15|1971-01-16||
TRIAL STUDY 134XCP|DS|16F375DC-DC27-461B-969E-1269DC53F4D9|817||||||OTHER EVENT||CONTINUATION TREATMENT|1970-02-26|1963-05-17||
TRIAL STUDY 134XCP|DS|17BF9A68-265F-4FCC-A499-615A1B71A8D6|818||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1972-11-23|1964-11-03||
TRIAL STUDY 134XCP|DS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF|819||||||PROTOCOL MILESTONE||TREATMENT|1971-07-02|1964-05-10||
TRIAL STUDY 134XCP|DS|B842981B-AD7A-4A03-8E84-D5FC887BAD60|820||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1962-09-05|1971-09-09||
TRIAL STUDY 134XCP|DS|07F7C4E7-7722-4916-AB89-46EF540E2BD7|821||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1972-05-07|1968-05-26||
TRIAL STUDY 134XCP|DS|58661394-906E-43F3-8935-150DF240A04C|822||||||OTHER EVENT||BLINDED TREATMENT|1971-09-21|1967-07-25||
TRIAL STUDY 134XCP|DS|B70F3694-B764-4B39-BFB9-B1281ED091B8|823||||||OTHER EVENT||SCREENING|1969-12-08|1963-05-03||
TRIAL STUDY 134XCP|DS|5B2471DB-807A-44F8-9529-D2319CCFE017|824||||||DISPOSITION EVENT||INDUCTION TREATMENT|1964-08-04|1971-05-24||
TRIAL STUDY 134XCP|DS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2|825||||||PROTOCOL MILESTONE||WASHOUT|1960-02-23|1960-12-11||
TRIAL STUDY 134XCP|DS|A6E00A2C-7DBC-4577-8873-C780F5A6B400|826||||||PROTOCOL MILESTONE||RUN-IN|1973-06-08|1960-06-23||
TRIAL STUDY 134XCP|DS|06611015-E99C-466B-B0B3-EBE10EA9E627|827||||||DISPOSITION EVENT||WASHOUT|1963-04-22|1965-02-05||
TRIAL STUDY 134XCP|DS|5AF91C46-87FC-4714-B956-A4ECFC87C30A|828||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1963-01-29|1965-05-23||
TRIAL STUDY 134XCP|DS|3DEA7E00-77B9-4710-A37E-577F925BFBD8|829||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1960-04-10|1962-07-05||
TRIAL STUDY 134XCP|DS|DC79E350-1B89-4518-8B42-5858F5270928|830||||||OTHER EVENT||WASHOUT|1964-11-14|1963-11-16||
TRIAL STUDY 134XCP|DS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726|831||||||PROTOCOL MILESTONE||WASHOUT|1972-01-19|1966-09-17||
TRIAL STUDY 134XCP|DS|7F51014D-D2B5-4956-9DD6-52676EB66ED7|832||||||OTHER EVENT||INDUCTION TREATMENT|1965-08-07|1971-10-08||
TRIAL STUDY 134XCP|DS|0568B2DD-3184-472D-89C6-66A5CE8AE00F|833||||||DISPOSITION EVENT||WASHOUT|1961-07-01|1960-05-16||
TRIAL STUDY 134XCP|DS|275DC6A6-598C-4997-A442-4A3916AC42BD|834||||||DISPOSITION EVENT||INDUCTION TREATMENT|1961-05-06|1970-07-19||
TRIAL STUDY 134XCP|DS|B949F90F-524D-4494-A63C-A05F56421EA1|835||||||DISPOSITION EVENT||INDUCTION TREATMENT|1964-04-01|1964-09-18||
TRIAL STUDY 134XCP|DS|152411EA-E7DA-4230-A8A6-163C8A8C0A58|836||||||DISPOSITION EVENT||FOLLOW-UP|1967-04-20|1967-10-05||
TRIAL STUDY 134XCP|DS|AB78662C-F90A-4193-9AC7-5621B497A18F|837||||||OTHER EVENT||WASHOUT|1973-03-08|1961-12-09||
TRIAL STUDY 134XCP|DS|84CD31FD-BCB9-4439-84F7-11C63D578108|838||||||DISPOSITION EVENT||SCREENING|1966-12-29|1960-10-04||
TRIAL STUDY 134XCP|DS|BB9A976D-48AC-4618-9BA1-683D97240F2B|839||||||PROTOCOL MILESTONE||OBSERVATION|1973-01-02|1969-09-19||
TRIAL STUDY 134XCP|DS|FA440C9B-0D7A-4656-BF17-D46289567FB0|840||||||PROTOCOL MILESTONE||TREATMENT|1964-08-07|1973-06-06||
TRIAL STUDY 134XCP|DS|1706BA4E-D2AB-4877-974A-17BDBD834FFF|841||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1968-12-29|1961-04-26||
TRIAL STUDY 134XCP|DS|15E3DD06-7F28-499B-9CF5-6EE5875095B5|842||||||PROTOCOL MILESTONE||SCREENING|1962-09-20|1967-11-03||
TRIAL STUDY 134XCP|DS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD|843||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1972-09-16|1960-02-14||
TRIAL STUDY 134XCP|DS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB|844||||||PROTOCOL MILESTONE||TREATMENT|1961-02-04|1971-06-11||
TRIAL STUDY 134XCP|DS|87ED1C08-AF47-4827-A897-E8FC24A69ECC|845||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1962-04-15|1962-02-27||
TRIAL STUDY 134XCP|DS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A|846||||||PROTOCOL MILESTONE||TREATMENT|1964-08-03|1967-02-05||
TRIAL STUDY 134XCP|DS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F|847||||||OTHER EVENT||FOLLOW-UP|1963-02-20|1966-11-13||
TRIAL STUDY 134XCP|DS|C817A043-1331-47AB-A627-D85893F9D61A|848||||||DISPOSITION EVENT||BASELINE|1961-01-31|1966-12-16||
TRIAL STUDY 134XCP|DS|DDD6F5D1-AE97-412C-A161-869C4178223A|849||||||DISPOSITION EVENT||OBSERVATION|1966-07-20|1967-04-21||
TRIAL STUDY 134XCP|DS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18|850||||||PROTOCOL MILESTONE||FOLLOW-UP|1965-09-01|1961-08-20||
TRIAL STUDY 134XCP|DS|25FB07EA-3CB8-430D-B775-CA0E9918C069|851||||||OTHER EVENT||RUN-IN|1970-04-23|1972-07-05||
TRIAL STUDY 134XCP|DS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A|852||||||DISPOSITION EVENT||FOLLOW-UP|1961-10-01|1962-09-11||
TRIAL STUDY 134XCP|DS|B49B9695-9815-4B7B-9F96-4EE6A4432062|853||||||DISPOSITION EVENT||FOLLOW-UP|1962-11-22|1967-12-24||
TRIAL STUDY 134XCP|DS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44|854||||||DISPOSITION EVENT||TREATMENT|1971-01-13|1967-02-04||
TRIAL STUDY 134XCP|DS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53|855||||||OTHER EVENT||BLINDED TREATMENT|1973-07-13|1961-12-12||
TRIAL STUDY 134XCP|DS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B|856||||||PROTOCOL MILESTONE||SCREENING|1968-09-21|1962-04-15||
TRIAL STUDY 134XCP|DS|07A934C8-0237-4B37-9FDD-503B8BF94357|857||||||PROTOCOL MILESTONE||OBSERVATION|1973-03-05|1970-10-29||
TRIAL STUDY 134XCP|DS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF|858||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1967-08-01|1971-05-17||
TRIAL STUDY 134XCP|DS|10E1249E-10AC-45E8-9896-84C7B0F548BC|859||||||OTHER EVENT||BLINDED TREATMENT|1961-09-15|1973-04-03||
TRIAL STUDY 134XCP|DS|6CA97CE0-D120-4E14-A82F-4799D2699110|860||||||OTHER EVENT||OBSERVATION|1963-09-30|1965-01-05||
TRIAL STUDY 134XCP|DS|D807C3F6-0955-4742-A29B-815682559530|861||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1967-10-02|1965-10-22||
TRIAL STUDY 134XCP|DS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75|862||||||PROTOCOL MILESTONE||SCREENING|1970-10-17|1973-07-24||
TRIAL STUDY 134XCP|DS|38C36B22-EC60-4D40-A1B6-71B17F8C8625|863||||||PROTOCOL MILESTONE||SCREENING|1961-01-16|1967-10-31||
TRIAL STUDY 134XCP|DS|E2F4144C-543D-4F55-A94E-58F244FB21D1|864||||||DISPOSITION EVENT||OBSERVATION|1964-07-12|1968-07-01||
TRIAL STUDY 134XCP|DS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8|865||||||DISPOSITION EVENT||FOLLOW-UP|1971-02-24|1963-10-05||
TRIAL STUDY 134XCP|DS|49B857CF-22F2-406F-A269-54944B23C236|866||||||DISPOSITION EVENT||SCREENING|1965-02-04|1971-07-27||
TRIAL STUDY 134XCP|DS|E09B394B-9E48-4132-B430-991DF1953A81|867||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1964-06-02|1969-10-28||
TRIAL STUDY 134XCP|DS|5FB65CB2-DB12-4D00-818E-C51992DC7273|868||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1960-03-09|1972-08-26||
TRIAL STUDY 134XCP|DS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6|869||||||PROTOCOL MILESTONE||BASELINE|1970-12-03|1967-07-15||
TRIAL STUDY 134XCP|DS|CB6A1101-1EF8-476D-BD15-B60EF323D740|870||||||DISPOSITION EVENT||INDUCTION TREATMENT|1967-09-23|1961-09-16||
TRIAL STUDY 134XCP|DS|3AED1654-6D9A-40EE-A560-99F51C469D63|871||||||OTHER EVENT||INDUCTION TREATMENT|1961-01-14|1970-04-01||
TRIAL STUDY 134XCP|DS|4C13FD80-8950-4194-B76C-F46B643BED82|872||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1969-01-20|1962-03-27||
TRIAL STUDY 134XCP|DS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2|873||||||DISPOSITION EVENT||RUN-IN|1966-07-17|1960-02-13||
TRIAL STUDY 134XCP|DS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2|874||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1973-01-14|1967-05-15||
TRIAL STUDY 134XCP|DS|CFFA0003-098B-486E-82DB-30838F6541DD|875||||||DISPOSITION EVENT||FOLLOW-UP|1969-07-21|1961-11-25||
TRIAL STUDY 134XCP|DS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D|876||||||DISPOSITION EVENT||INDUCTION TREATMENT|1961-11-30|1967-01-11||
TRIAL STUDY 134XCP|DS|3F29184F-1963-4EC7-881A-61C9DEF95D2D|877||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1965-10-02|1968-04-03||
TRIAL STUDY 134XCP|DS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3|878||||||OTHER EVENT||OPEN LABEL TREATMENT|1968-06-01|1962-12-28||
TRIAL STUDY 134XCP|DS|D9C32CF1-51C7-412D-A030-682B2860F89D|879||||||OTHER EVENT||BASELINE|1967-11-13|1961-04-22||
TRIAL STUDY 134XCP|DS|102F6B51-5A86-497B-A36D-13FB77928C39|880||||||OTHER EVENT||BLINDED TREATMENT|1962-06-25|1970-07-03||
TRIAL STUDY 134XCP|DS|C123D04C-1AA4-418D-B68C-EC9D410376F0|881||||||DISPOSITION EVENT||SCREENING|1967-08-08|1971-12-08||
TRIAL STUDY 134XCP|DS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6|882||||||DISPOSITION EVENT||FOLLOW-UP|1960-04-07|1960-04-05||
TRIAL STUDY 134XCP|DS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4|883||||||DISPOSITION EVENT||WASHOUT|1966-07-08|1964-05-04||
TRIAL STUDY 134XCP|DS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5|884||||||PROTOCOL MILESTONE||BASELINE|1970-08-16|1967-03-10||
TRIAL STUDY 134XCP|DS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC|885||||||OTHER EVENT||WASHOUT|1963-02-11|1966-03-09||
TRIAL STUDY 134XCP|DS|E3310689-5727-4970-A675-A58931E406FA|886||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1971-10-10|1966-09-20||
TRIAL STUDY 134XCP|DS|D5359BBA-960E-4392-996A-BCDD8637894A|887||||||DISPOSITION EVENT||OBSERVATION|1972-09-24|1968-10-04||
TRIAL STUDY 134XCP|DS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5|888||||||PROTOCOL MILESTONE||WASHOUT|1964-10-21|1972-11-22||
TRIAL STUDY 134XCP|DS|EED3F55E-892E-46C6-8B0A-30D2E1112072|889||||||OTHER EVENT||WASHOUT|1966-10-03|1963-05-19||
TRIAL STUDY 134XCP|DS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF|890||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1972-08-18|1972-04-30||
TRIAL STUDY 134XCP|DS|B865DADD-9A4E-4521-A2E8-104D709F4144|891||||||OTHER EVENT||BASELINE|1968-07-12|1967-07-03||
TRIAL STUDY 134XCP|DS|D8C78860-7893-4239-8F29-A0EE98C90310|892||||||OTHER EVENT||FOLLOW-UP|1967-06-15|1966-06-21||
TRIAL STUDY 134XCP|DS|841D0118-C3F9-4169-B43E-D88CEB2795BA|893||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1961-10-11|1969-03-29||
TRIAL STUDY 134XCP|DS|9C3C0334-F7A4-4530-A6D3-574C039979E7|894||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1968-05-18|1973-05-30||
TRIAL STUDY 134XCP|DS|FE955CB9-9992-4521-8788-7597AF40F214|895||||||PROTOCOL MILESTONE||RUN-IN|1973-06-21|1969-12-03||
TRIAL STUDY 134XCP|DS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D|896||||||DISPOSITION EVENT||FOLLOW-UP|1967-03-07|1969-06-07||
TRIAL STUDY 134XCP|DS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E|897||||||DISPOSITION EVENT||WASHOUT|1970-07-15|1960-04-28||
TRIAL STUDY 134XCP|DS|28B6CF51-A007-4CED-8247-37BD468F41C5|898||||||DISPOSITION EVENT||RUN-IN|1968-08-24|1970-02-19||
TRIAL STUDY 134XCP|DS|4E600C41-1B27-4042-B48E-B60489701D2D|899||||||DISPOSITION EVENT||TREATMENT|1964-09-17|1964-03-19||
TRIAL STUDY 134XCP|DS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD|900||||||OTHER EVENT||BASELINE|1967-07-12|1968-11-22||
TRIAL STUDY 134XCP|DS|00D760E7-DC21-41A8-AD28-FF48A5C21E83|901||||||OTHER EVENT||FOLLOW-UP|1972-12-20|1960-05-08||
TRIAL STUDY 134XCP|DS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3|902||||||PROTOCOL MILESTONE||TREATMENT|1963-01-24|1962-03-10||
TRIAL STUDY 134XCP|DS|4EC25C9E-F259-405B-8B7D-3C9640FB9748|903||||||DISPOSITION EVENT||FOLLOW-UP|1962-02-20|1964-12-28||
TRIAL STUDY 134XCP|DS|FF1CC617-040D-42E9-AD31-32E7B8DAED24|904||||||DISPOSITION EVENT||BASELINE|1960-09-06|1971-03-10||
TRIAL STUDY 134XCP|DS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53|905||||||OTHER EVENT||TREATMENT|1960-06-28|1973-05-18||
TRIAL STUDY 134XCP|DS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F|906||||||OTHER EVENT||WASHOUT|1961-09-19|1960-01-04||
TRIAL STUDY 134XCP|DS|BFA83769-F31F-49AE-8C43-49046C719D69|907||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1965-12-26|1963-11-14||
TRIAL STUDY 134XCP|DS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E|908||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1961-03-23|1968-07-02||
TRIAL STUDY 134XCP|DS|91838668-D463-4728-A581-2E1987592885|909||||||DISPOSITION EVENT||OBSERVATION|1964-09-07|1966-11-27||
TRIAL STUDY 134XCP|DS|DE440A90-82D5-4269-A48B-47E2F5495440|910||||||DISPOSITION EVENT||WASHOUT|1965-08-07|1960-06-07||
TRIAL STUDY 134XCP|DS|74CA3A61-3179-43F1-8721-2582F50C44EF|911||||||OTHER EVENT||OPEN LABEL TREATMENT|1972-09-22|1962-08-11||
TRIAL STUDY 134XCP|DS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE|912||||||DISPOSITION EVENT||TREATMENT|1966-04-16|1960-12-30||
TRIAL STUDY 134XCP|DS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE|913||||||DISPOSITION EVENT||TREATMENT|1969-03-12|1964-07-11||
TRIAL STUDY 134XCP|DS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27|914||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1965-04-03|1965-02-23||
TRIAL STUDY 134XCP|DS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86|915||||||PROTOCOL MILESTONE||OBSERVATION|1972-11-25|1969-07-01||
TRIAL STUDY 134XCP|DS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2|916||||||DISPOSITION EVENT||BLINDED TREATMENT|1961-08-26|1961-06-16||
TRIAL STUDY 134XCP|DS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9|917||||||OTHER EVENT||INDUCTION TREATMENT|1968-02-04|1964-08-26||
TRIAL STUDY 134XCP|DS|687E56D1-7E45-4598-819A-A0D8D770F406|918||||||PROTOCOL MILESTONE||BASELINE|1961-03-29|1960-10-08||
TRIAL STUDY 134XCP|DS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849|919||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1970-02-14|1963-07-30||
TRIAL STUDY 134XCP|DS|F536FDD9-881B-41AD-B863-FE8AB14062A1|920||||||DISPOSITION EVENT||FOLLOW-UP|1965-04-26|1968-11-10||
TRIAL STUDY 134XCP|DS|CB726766-A812-45B3-95CA-D1AD8F697FD3|921||||||PROTOCOL MILESTONE||FOLLOW-UP|1960-06-06|1971-02-18||
TRIAL STUDY 134XCP|DS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830|922||||||PROTOCOL MILESTONE||BASELINE|1963-12-09|1965-01-09||
TRIAL STUDY 134XCP|DS|20DC654F-595C-410D-A340-465A23434D42|923||||||PROTOCOL MILESTONE||RUN-IN|1961-04-09|1966-01-08||
TRIAL STUDY 134XCP|DS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1|924||||||OTHER EVENT||TREATMENT|1972-09-16|1968-01-19||
TRIAL STUDY 134XCP|DS|4EA8DC88-09C8-4954-A469-D8E12F01CB56|925||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1970-06-08|1960-01-15||
TRIAL STUDY 134XCP|DS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7|926||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1964-10-13|1967-03-07||
TRIAL STUDY 134XCP|DS|521B1614-9092-4F89-A47F-728C66E01B23|927||||||DISPOSITION EVENT||TREATMENT|1960-11-19|1963-02-09||
TRIAL STUDY 134XCP|DS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D|928||||||DISPOSITION EVENT||TREATMENT|1966-08-24|1961-05-15||
TRIAL STUDY 134XCP|DS|FF6B8B49-3C82-459D-A35D-61136FC594D2|929||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1963-10-27|1964-04-21||
TRIAL STUDY 134XCP|DS|2196D9F4-937A-4662-B24B-AC9D472E0393|930||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1966-09-27|1971-02-19||
TRIAL STUDY 134XCP|DS|F192452A-4088-46AA-9DD1-8D14809E18F6|931||||||OTHER EVENT||FOLLOW-UP|1973-02-04|1962-10-16||
TRIAL STUDY 134XCP|DS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5|932||||||PROTOCOL MILESTONE||OBSERVATION|1966-05-30|1972-07-24||
TRIAL STUDY 134XCP|DS|0D51A87E-2597-4B2D-A7B5-E533790E917D|933||||||PROTOCOL MILESTONE||BLINDED TREATMENT|1968-03-19|1962-05-19||
TRIAL STUDY 134XCP|DS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4|934||||||DISPOSITION EVENT||TREATMENT|1965-01-16|1967-09-11||
TRIAL STUDY 134XCP|DS|16075684-F04D-4CB8-970A-0819378790EB|935||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1966-02-26|1969-08-13||
TRIAL STUDY 134XCP|DS|3527E844-D4D5-480A-B6D6-04C5DC0A3380|936||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1966-04-02|1970-01-22||
TRIAL STUDY 134XCP|DS|DFB0DF52-4D95-4A26-B28F-071774D78426|937||||||OTHER EVENT||SCREENING|1964-05-18|1964-12-07||
TRIAL STUDY 134XCP|DS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439|938||||||PROTOCOL MILESTONE||BASELINE|1966-04-05|1969-10-07||
TRIAL STUDY 134XCP|DS|CFF20837-0091-467E-ABDE-72645BAFC849|939||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1966-02-05|1969-05-27||
TRIAL STUDY 134XCP|DS|C79756C8-8601-4770-8BC2-7A530428BA82|940||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1966-08-08|1967-05-09||
TRIAL STUDY 134XCP|DS|5533A669-828B-4CA3-BEC3-849CE7384167|941||||||PROTOCOL MILESTONE||OBSERVATION|1968-06-06|1968-10-01||
TRIAL STUDY 134XCP|DS|C711ADD3-F398-4161-BE13-B75BEDF91402|942||||||DISPOSITION EVENT||BASELINE|1960-02-05|1962-01-04||
TRIAL STUDY 134XCP|DS|2CD70FFA-5977-4718-961B-6D67368F99B8|943||||||DISPOSITION EVENT||CONTINUATION TREATMENT|1962-11-28|1968-05-09||
TRIAL STUDY 134XCP|DS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A|944||||||DISPOSITION EVENT||TREATMENT|1968-08-24|1969-03-08||
TRIAL STUDY 134XCP|DS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7|945||||||PROTOCOL MILESTONE||SCREENING|1968-05-15|1970-05-06||
TRIAL STUDY 134XCP|DS|43E00B7D-684F-4BAC-A135-E65C22B191AD|946||||||OTHER EVENT||OPEN LABEL TREATMENT|1969-05-02|1972-06-05||
TRIAL STUDY 134XCP|DS|25680BE0-7CE5-4B76-A48E-2D977A07E749|947||||||OTHER EVENT||BASELINE|1967-06-30|1964-08-15||
TRIAL STUDY 134XCP|DS|67CA2619-351F-493E-93B2-5CDC9AF99C8B|948||||||OTHER EVENT||BASELINE|1964-01-16|1967-05-15||
TRIAL STUDY 134XCP|DS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA|949||||||PROTOCOL MILESTONE||SCREENING|1965-06-28|1971-09-18||
TRIAL STUDY 134XCP|DS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86|950||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1971-04-23|1966-01-24||
TRIAL STUDY 134XCP|DS|51B01BE3-230D-4AE0-A229-81EF519EA932|951||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1962-04-08|1962-05-18||
TRIAL STUDY 134XCP|DS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE|952||||||OTHER EVENT||TREATMENT|1963-12-08|1968-08-05||
TRIAL STUDY 134XCP|DS|01FD66DA-C67B-48A7-9320-F29C6C226155|953||||||OTHER EVENT||RUN-IN|1960-03-21|1965-10-18||
TRIAL STUDY 134XCP|DS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C|954||||||DISPOSITION EVENT||BASELINE|1972-09-25|1961-03-16||
TRIAL STUDY 134XCP|DS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2|955||||||OTHER EVENT||CONTINUATION TREATMENT|1963-01-10|1971-02-03||
TRIAL STUDY 134XCP|DS|81E3641F-6145-4B3C-9E26-8DEC1200509D|956||||||DISPOSITION EVENT||BASELINE|1962-08-16|1960-05-03||
TRIAL STUDY 134XCP|DS|8F3D0A71-FD09-4E43-BC54-0562AF99306E|957||||||PROTOCOL MILESTONE||FOLLOW-UP|1965-03-12|1966-02-16||
TRIAL STUDY 134XCP|DS|BE750F04-5992-42B5-A084-A33D6FBBFD2E|958||||||OTHER EVENT||BLINDED TREATMENT|1967-12-31|1969-12-01||
TRIAL STUDY 134XCP|DS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89|959||||||DISPOSITION EVENT||FOLLOW-UP|1968-11-03|1960-05-01||
TRIAL STUDY 134XCP|DS|8417B146-336C-4777-A566-C1D086F39430|960||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1966-02-12|1968-07-26||
TRIAL STUDY 134XCP|DS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7|961||||||PROTOCOL MILESTONE||RUN-IN|1971-10-20|1970-03-26||
TRIAL STUDY 134XCP|DS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE|962||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1967-11-09|1961-02-09||
TRIAL STUDY 134XCP|DS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB|963||||||OTHER EVENT||BASELINE|1971-03-04|1962-08-31||
TRIAL STUDY 134XCP|DS|2926D795-9C17-4440-8411-68525E93E78D|964||||||DISPOSITION EVENT||BASELINE|1965-02-17|1968-06-21||
TRIAL STUDY 134XCP|DS|BA3378F3-C308-469F-9818-9AD811086548|965||||||PROTOCOL MILESTONE||BASELINE|1966-12-01|1961-07-25||
TRIAL STUDY 134XCP|DS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA|966||||||DISPOSITION EVENT||OPEN LABEL TREATMENT|1973-03-11|1962-06-17||
TRIAL STUDY 134XCP|DS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6|967||||||OTHER EVENT||SCREENING|1960-01-31|1972-02-26||
TRIAL STUDY 134XCP|DS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7|968||||||DISPOSITION EVENT||RUN-IN|1970-08-21|1964-12-08||
TRIAL STUDY 134XCP|DS|15594D4E-1DAE-449F-AA52-9B0A926D9985|969||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1964-10-11|1971-05-12||
TRIAL STUDY 134XCP|DS|079DEA7B-A617-4787-9872-025F4248ABFF|970||||||PROTOCOL MILESTONE||INDUCTION TREATMENT|1962-12-14|1966-10-04||
TRIAL STUDY 134XCP|DS|3178AE30-9653-4470-84E4-FB0E4587DF6B|971||||||DISPOSITION EVENT||SCREENING|1973-04-23|1965-01-21||
TRIAL STUDY 134XCP|DS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A|972||||||DISPOSITION EVENT||FOLLOW-UP|1966-02-15|1967-08-25||
TRIAL STUDY 134XCP|DS|D274C760-A607-4DA8-ACD3-346EF6E191D2|973||||||OTHER EVENT||SCREENING|1961-03-17|1968-05-03||
TRIAL STUDY 134XCP|DS|F5B7E82D-49AD-422E-9C38-5681105094AA|974||||||DISPOSITION EVENT||WASHOUT|1966-04-08|1965-04-20||
TRIAL STUDY 134XCP|DS|AF8D32B4-B2CC-4EE3-A612-179814C691B8|975||||||PROTOCOL MILESTONE||OBSERVATION|1962-07-23|1971-11-05||
TRIAL STUDY 134XCP|DS|64153B43-9DDC-473D-97E1-0E2E8C3E8116|976||||||OTHER EVENT||OBSERVATION|1963-04-13|1972-03-30||
TRIAL STUDY 134XCP|DS|0F5775AD-1D20-4B59-8558-8A41C12E03D0|977||||||PROTOCOL MILESTONE||RUN-IN|1967-04-02|1968-05-10||
TRIAL STUDY 134XCP|DS|DF533087-690C-489A-9163-9D4503B7BCC9|978||||||DISPOSITION EVENT||OBSERVATION|1960-05-25|1964-11-02||
TRIAL STUDY 134XCP|DS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919|979||||||DISPOSITION EVENT||WASHOUT|1970-05-28|1963-11-28||
TRIAL STUDY 134XCP|DS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5|980||||||OTHER EVENT||BASELINE|1968-01-05|1968-08-07||
TRIAL STUDY 134XCP|DS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4|981||||||PROTOCOL MILESTONE||SCREENING|1973-04-13|1971-05-21||
TRIAL STUDY 134XCP|DS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F|982||||||OTHER EVENT||OPEN LABEL TREATMENT|1966-04-25|1970-07-17||
TRIAL STUDY 134XCP|DS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E|983||||||DISPOSITION EVENT||WASHOUT|1961-08-30|1964-06-13||
TRIAL STUDY 134XCP|DS|219A70B2-48A6-407C-B901-9847583DB5F4|984||||||OTHER EVENT||INDUCTION TREATMENT|1969-08-02|1965-09-20||
TRIAL STUDY 134XCP|DS|CF3AC42D-DFBA-448E-A688-46A87D6264EB|985||||||OTHER EVENT||TREATMENT|1963-08-10|1967-02-11||
TRIAL STUDY 134XCP|DS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4|986||||||OTHER EVENT||BASELINE|1963-01-31|1965-11-12||
TRIAL STUDY 134XCP|DS|D19D43A5-DFE6-415D-86B7-6A767A357BC9|987||||||DISPOSITION EVENT||TREATMENT|1970-09-28|1967-01-05||
TRIAL STUDY 134XCP|DS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F|988||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1963-04-10|1964-07-12||
TRIAL STUDY 134XCP|DS|7D307F63-4A25-4E7D-9980-16764AE5C4A4|989||||||DISPOSITION EVENT||INDUCTION TREATMENT|1961-01-04|1968-11-30||
TRIAL STUDY 134XCP|DS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D|990||||||DISPOSITION EVENT||WASHOUT|1964-03-13|1967-12-21||
TRIAL STUDY 134XCP|DS|F4718E0D-4DD9-442E-8907-076551C83AEE|991||||||DISPOSITION EVENT||LONG-TERM FOLLOW-UP|1966-01-15|1965-08-08||
TRIAL STUDY 134XCP|DS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9|992||||||OTHER EVENT||LONG-TERM FOLLOW-UP|1972-05-13|1973-08-14||
TRIAL STUDY 134XCP|DS|E86F996D-3A96-4C36-82B2-1AC4B4906F49|993||||||OTHER EVENT||CONTINUATION TREATMENT|1962-11-20|1961-12-11||
TRIAL STUDY 134XCP|DS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C|994||||||DISPOSITION EVENT||FOLLOW-UP|1964-01-14|1965-06-25||
TRIAL STUDY 134XCP|DS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF|995||||||DISPOSITION EVENT||FOLLOW-UP|1970-05-15|1960-01-06||
TRIAL STUDY 134XCP|DS|28E9B15E-4757-42F5-8AE7-2C868904F88B|996||||||PROTOCOL MILESTONE||OPEN LABEL TREATMENT|1963-01-18|1970-02-19||
TRIAL STUDY 134XCP|DS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B|997||||||PROTOCOL MILESTONE||CONTINUATION TREATMENT|1961-04-06|1961-01-14||
TRIAL STUDY 134XCP|DS|2E1011F1-A091-4E7E-B661-477A1F6DD39A|998||||||PROTOCOL MILESTONE||LONG-TERM FOLLOW-UP|1971-07-24|1970-05-31||
TRIAL STUDY 134XCP|DS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49|999||||||OTHER EVENT||RUN-IN|1965-05-21|1962-10-20||
TRIAL STUDY 134XCP|DS|176B6882-0C9E-435E-9842-FF8714BC9CAF|1000||||||OTHER EVENT||OPEN LABEL TREATMENT|1964-08-25|1966-07-27||
